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CLINICAL COURSE OF MINIMAL CHANGE DESEASE IN ADULTS
B.Margelos, N.Nikolopoulou, Fl.Sotsiou, Gr.Vosnides,
A.Poulopoulos, P.Mangana, N.Tsians, L.Marinos,
D.Xadjiyannakos, Th.Apostolou, A.Billis
Division of Nephrology and Department of Pathology,
Evangelismos Hospital, Athens, Greece
The clinical course of adult minimal change desease (MCD)
has not been extensively studied. Therefore, we evaluated
the outcome of 20 patients (pts) (9M, llF),aged 16 to 67
years, with nephrotic syndrome (N.S.) and normal renal
function who were under our care from 1979 to 1989 for MCD
diagnosed by renal biopsy. Eight pts (40%)with proteinuria
5,5gI24h received no treatment and in all of them, within
1—16 months, complete (6 pts) or partial (2 pts) remission
of proteinuria, without subsequent relapses, was observed.
Of the remaining 12 pts with proteinuria 5,5g/24h who
received steroids,8(67%l responded whereas another 2(16,7%)
responded when cyclophosphamide was added. Five of these
10 pts developed subsequently 1—4 relapses of the N.S.
which responded temporarily (4 pts) or permanently (1 pt)
to steroids and/or cyclophosphamide. In 4 pts, who did not
respond to treatment or relapsed, a smcond renal biopsy
was done 18—66 months after the first and in 3 of them
(15% of all pts), who developed renal impairment, focal
segmental glomerulosclerosis was found. At the end of the
follow—up period (8—109 months) 16 pts (80%) had remission
of proteinuria (12 complete, 4 partial) and normal renal
function, 1 pt had renal impairment, 2 pts were on chronic
hemodialysis and 1 pt had died because of myocardial
infraction.
It is concluded that in adult MCD: 1) When proteinuria is
not severe, spontaneous remission occurs within one year.
2) A high propotion of pts respond initially to steroids
and/or cyclophosphamide, but relapses occur frequently. 3)
In pts developing impairment of renal function, focal
segmental glomerulosclerosis should be excluded.
STEROIDS AND CHLORAMDUCIL IN IDIOPATHIC MEMBRANOUS
GLOMERULONEPNRITIS (IMGN): IS THERE ANY THERAPEUTIC
EFFECT?
A.Billis, Gr.Vosnides, N.Nikolopoulou, M.Siakotos,
G.Stavyinoudakis, I.Malegos, A.Poulopoulos, A.Drouzas,
8.Margellos, M.Zavros.
Division of Nephrology, Evangelismos Hospital, Athens,
Greece
In order to evaluate the therapeutic effect of steroids
and chlorambucil in IMGN, these drugs were given in a
prospective clinical trial in 26 patients (pts) (Group I),
18 to 62 years old with IMGN, severe nephrotic syndrome
and normal (21 pts) or mildly reduced (serum creatinine
1,4—2,0 mg%) (5 ptsl renal function. Eleven of these pts
had received in the past steroids without effect. 24 pts
with IMGN, who were hospitalized over the same period but
received no treatment, were used as controls (Group III.
The groups were matched for sex, age, severity of
proteinuria, renal function and histological grade of the
glomerular lesions. The treatment lasted 6 months and
consisted of alternating monthly courses of steroids
)methylprednisolone IV, lg daily for 3 days followed by
prednisolone 0,5mg/kg daily for 27 days) and chloraebucil
(0,2mg/kg daily). Three pts discontinued treatment because
of side—effects (hepatotoxicity 1, severe leucopenia 1,
oeurotoxicity 1). At the end of the follow—up period
46,4*32 months after treatment for group I and 60,5*33
months for group II): 1) Nine pts from group I (35%) and
13 from group II (54,2%) had compete or partial remission
of proteiouria (p<0,05). 2) Six pts from group I (23%) and
7 from group II (29,2%) had developed significant
deterioration of renal function (0,05<p<O,1O) which in 5
pts (2 of group I and 3 of group II) had reached end—stage
reoml failure. 3) One pt from group II had died suddenly.
In conclusion, the administration of steroids and
chloraebucil in our pts had no a significatn therapeutic
effect -in the proteinuria or the progression of renal
damage and, in addition, was no free of severe side—
effects.
PROGNOSIS OF MICROSCOPIC FOLYARTERITIS )MP) WITH RENAL
INVOLVEMENT: OBSERVATIONS IN 30 PATIENTS
D.Nadjiyannmkos Gr.Vosnides, Fl.Sotsiou, N.Nikolopoulou.
Sp.Michael, A.Poulopoulos, B.Margellos, J.Malegos,
L.Marinos, M.Tziamalis, A.Billis
Division of Nephrn)ogy and Departsent of Pathology,
Evanelissos Hospital, Athens, Division of Nephrology,
Laikon General Hospital, Athens Greece
A considerable isprovesent in the survival of patients
(pts) with NP and renal involvement (65—BOX at 5 years)
has been recently reported (1,2). We evaluated the
prognosis of the disease in 3/) pts (1SM, 1SF), aged 30—70
years,who were hospitalized frns 1981 to 1989 for NP and
in whos renal biopsy showed segmental necrotizing
gloserulonephritis and/or extraglomerular vasculitis. Pts
with Henoch—Schonlein purpura, SLE and Wegener granuloma—
tosis were excluded. At presentation, 20 pts had
multisystes manifestations, 16 pts had rapid deterioration
of renal function (oliguric in 6 I and B pts necessitated
dialysis. Therapeutically, 27 pts were put on steroids
and, in 23 of them, cyclophosphamide orally (2 mg/kg/day,
17 pts) or intravenously (0,75—1,0 g/month, 6 pts) was
added. Three pts died in the acute stage of the illness
(within 2 months). Of the remaining pta, at the end of the
follow—up period (3—63,5 months) 4 had died ,5 were on
hesodia)ysis ,l5 had mild to moderate renal failure and 3
had normal renal function. The cumulative S—year survival
rate of the pts was 657.. The main side—effect of treatment
was leucopeota in 7 pts who received oral
cycl ophosphami de.
It is concluded that :l)The late prognosis of the disease
in our pts was comparable to that recently reported. 2) A
considerable proportion of our pts who were taking
cyclophosphamide orally developed leucopenia.
l)Savage C.O.et al 1985. 2(Fuiano G.et al 1988
LONG - TERM OUTCOME IN PATIENTS WITH IDIOPATIIIC
MEMGRANOUS NEPHROPATHY )IMN(: THE CASE OF
TREATMENT
8. Alexspsulos, G. Sakellarisu, 0. Memmos, K. Karamitsoe, M.
Leontsini, M. Papadimitrisu
Dept sf NephrolsEy, Aristotelian University af Thessalsniki,
Hippokration General Hospital, Thessalsniki
Dept sf Pathology, Hippokration Genera) Hsspita) ,Thessahiniki
The clinical course sf31 patients with IMN ever the last 10 yeare was
retrospectively studied. Male: female ratis mas 2.1:) and the mean age
(± SD) at the time sf diagzissis 48±12 yearv Nephrotic syndrame
(NS) was diagnssed in 28 patients (90%), micrescepic haematuria in.?
(23%) and arterial hypertensisn in 9 (29%). Mean proteinuria ) SD)
at diagnssis was 5.3 (±2.5) E/24h. Stersids a)sne or in combinatisn
with immunosuppressive drugs (IS) were Eiven in 29 patients while 2
received only symptomatic treatment. The mean period ef follow-up
(±50) was 50,4 (±36,4) msoths. Thirteen patients (45%) shswed a
complete ress)ution of NS, 11(38%) a partial sne and 5 patients (17%)
did net respond at all. Recurrence sf NS after the initial csmplete or
partial response was recarded in 7 patients and delayed spontaneous
remisoisn in anether one. Mean plasma creatinine (±50) rose from
1.3 (±0.4) to 1.7 (±1.1) mgldl during fellow - up. In addition, 2
patients (1 with resistant NS and 1 with impaired renal function on
admission) reached finally ESRD. Cushingoid, diabetes mellitus and
cardiovoocular problems were the main adverse effects of the
treatment.
In conclusion, treatment with steroids and IS oeemo to lead to a
aignificant reduction of proteinuria in the majority of patients with
IMN. This favourable effect is mainly evident during the first months
after the treatment. Recurrence of NS may occur after the initial
response. Resistant NS and impaired renal function on initial
presentation may represent indices of poor prognosis.
© 1991 by the International Society of Nephrology
TREATMENT OF NEPHROTIC HYPERLIPIDEMIA
M.Elisaf, M.Oardamanis, G.Sferopoulos, M.Pappas,
C.Korakis, K.C.Siamopoulos
Department of Internal Medicine, School of Medicine,
University of loannina, loannina
Abstracts
Hyperlipidemia is relatively common in patients with
nephrotic syndrome and contributes to the increased cardio-
vascular risk as well as to the glomerular pathology.
The aim of this study was the evaluation.of the effi-
cacy and safety of a lipid lower drug, lovastatin, in pa-
tients with nephrotic syndrome. We studied 13 patients (6
male, 7 female) with a mean age of 52 (range 41 to 67) ye—
irs with nephrotic syndrome and hyperlipidemia. The dura-
tion of the disease was longer than 6 months. The etiology
of nephrotic syndrome was: idiopathic membranous glomeru-
lonephritis (9 patients), focal glomerulosclerosis (3 pa-
tients) and lupus nephritis (1 patient). None of the pa-
tients had primary hyperlipidemia, diabetes mellitus or se-
vere renal failure and all patients were on a diet poor
in cholesterol for at least 6 months. Eleven patients were
receiving small doses of furosemide (20 to 40 mg/day) and
2 patients small doses of methylprednisolone (4 and ares—
pectively).All patients received Lovastatin 2Ong/day. After
6—12 weeks of treatment the effects of the drug on lipo-
are 5h1re12jablr ckt thaapy
Ththl cholesterol 29 C 0.001
Triglycerides (og/di) 179 t 222 198 t 107 C 0.05Lolciolsotsrsl (sg/dl) 246 87 154 27 C 0.01
BOLcislesterel (sig/di) 16.5 7.1 35 9 NI
During therapy no side effects were noticed and serum
creatinine as well as proteinuria were unchanged.
In conclusion: Lovastatin is a safe, well tolerated and
efficient antilipemic drug for treating nephrotic hyperli—
pidemia.
TREATMENT OF LIPID ABNORMALITIES IN PATIENTS WITH
CHRONIC RENAL FAILURE (CRF)
M.Elisaf, G.Sferopoulos, M.Dardamanis, M.Pappas,
K.C.Siamopoulos
Department of Internal Medicine, School of Medicine,
University of loannina, loannina
Greece
The type of lipid abnormalities in patients with CRF
receiving hemodialysis or peritoneal dialysis was studied.
In addition the safety and efficacy of gemfibrozil,a lipid
lower drug, was evaluated. Thirty-seven patients,13 on co-
ntinuous ambulatory peritoneal dialysis (CAPO) and 24 re-
ceiving chronic hemodialysis were studied. The mean value
of total cholesterol was 192±lOmg/dl (±1SD), of triglyce-
rides 242±200mg/dI (±1SD) and of HoLcholesterol 29±g.2mg/
dl (±1SD). There were no statistical significant diffe-
rences in the values of the above parameters between hamo—
dialysis and CAPD patients. As a control grouo. 6 patients
with primary hyperlipidemia (triglycerides >400njg/dl and
HOLcholesterol <32eg/dl) warm also studied. In 25 patients
who had elevated triglyceride levels (>400mg/dl) or very
low levels of HOLcholesterol (<28mg/dl) as well as in the
control group, gemfibrozil 600mg b.i.d. was given. Twelve
patients and the control group completed 12 weeks of trea-
tment. The effects of the drug on lipid prifile are shown
in the table.
Pstlssts costrois
Before After Before After
ts5rait txm6oat p ttsoemt txspst p
Ime/dil Ise/dil Ime/dil (eg/di)
cholesterol 261±41 203±43 C0.00i 265054 218±57 NI
Triglyceride 383±227 201±60 C0.05 710±210 260±80 =0.001
BoLohoiestsrol 26±3 26±5 NI 30±2 38±3 C0.0O1
No significant side effects were observed.
In conclusion:Gemfibrozil reduced total cholesterol and
triglyceride levels in patients with CRF and in the control
population. However,unlika the increase of HOL cholesterol
chserved in the control population, our OlE patients did not benefit.
If the results of our prelinenary study should be confinied by a lar-
ger percentage of pitients, drug therapy is questionable.
THE CLINICAL PICTURE AND EVOLUTION OF LUPUS NEPHRITIS
K.C.Siamopoulos, A.Drosos, Fl.Sotsiou, Li.Strikar,
D.Psihos, M.Elisaf and H.M.Moutsopoulos
Department of Jnternal Medicine, University of Ioannina,Greece
Department of Pathology,5EYAGELISMOS5 Gen.Hospital
Athens,Greece. National Institutes of Health,Bethesda,
Maryland, U.S.A.
We describe our axpbrence of the long term follow up
of patients with lupus nephritis (LGN).Thirty six patients
(31 female, 5 male) with a mean age of 37 (15—57)years we-
re stuqied. The diagnosis for both the SLE and LGN was ma-
de by the criteria of the American Rheumatology Associa-
tion (1982). All patients underwent a succesful percutane-
ous renal biopsy. According to the WHO criteria, type I or
II LGN was found in 6 (17%), type III in 2 (5%),type IV in
20 (56%) and type V inS (22%) patients.At the time of the
biopsy proteinuria was fluctuated between 0,5 aM 13,6 g/24h.
Eleven (30%) patients with type IV or V LGN had naphrotic
syndrome and 6 (17%) diminished renal function. After bio-
psy, 32 patients were followed for a mean tine of 49(12-168)
rnoqths. During the follow up 2 patients died, 1 due to se—
pticemia and the other one due to neoplesia.Corticosteroids
nere gihen in all patients, while azathioprime and cyclo—
phoxphamide either alone or in combination sore given to 29
patients. Intravenous courses of cyclophosphamide were gi-
ven in 9 patients with type IV or V LGN.At the latest fol-
low up, 2 patients had a sligth reduction of renal function
and 7 had proteinuria between 0,5 and 4,8 g/24h. Three of
them had nephrotic syndrmrm and an initial histological dia-
gnosis II,IV or V type of LGN. In 4 out of 5 patients a
sicond renal biopsy revealed histological transformation of
LGN; The disease remission was accompanied by clinical im-
provement, an increase of C3/C4 and reduction of the anti
ds—DNA titers.
In conclusion, the long term follow up of our patients showed
that, the LGN even in cases with severe histological and
clinical pictures, responds satisfactiorily to the combina-
tion of immunosupressive drugs.
RENAL PATHOLOGY AND CLINICAL COURSE
OF SILENT LUPUS NEPHRITIS
K.C.Siamopoulos, A.Drosos, Fl.Sotsiout, D.Psihos,
M.Elisaf and H.M.Moutsopoulos
Departments of Internal Medicine, University of loannina
and Pathologya, of EVAGELISMOS Gen. Hospital,
Athens, Greece
Unlike the usefulness of renal biopsy in patients with
systemic lupus erythematosus (SLE) and clinical renal ab-
normalities, the value of renal biopsy in patients with SEt
and without clinical renal involvement is a controversial
issue. We analyzed data from 12 SLE female patients aged
34.4(16—64) years who were biopsied without clinical renal
abnormalities (silent Luous nephritis). All patients ful-
filled at least 4 of the 11 American Rheumatism Association
criteria (1982) for the diagnosis of SLE ano none of them
was receiving immanosupresaive drugs before the renal biopsy.
At the time of biopsy renal function was normal, proteinu—
tie was less than O.5g/24h and no active urire swiiment was
found. According to the WHO criteria type I glomerular le-
sions were found in 4 cases, type II in 5, type III in 1
and type I or II was reported for 2 patients. After biopsy,
the patients were followed for a mean duration of 52(16—72)
months. Ourinq this time serum creatinine remained within
normal limits in all patients. In one patient nephro—
tic syndrome developed 72 months later. In the remaining 11
patients no significant proteinuria or active sediment was
noticed. Small doses of corticosteroids were given to 11
patients and hydrosychloroquiee to 7. This treatment was
introduced for alleviation of the estrarenal nunifestations.
In conclusion, significant renal pathology in patients with
silent lupus nephritis is rare. Therefore, renal biopsie
is not considered an important diagnostic and prognostic
procedure. However, it could be argued that corticoste—




COMPARATIVE EVALUATION OF RECTAL AND RENAL BIOPSY
IN THE DIAGNOSIS OF SYSTEMIC AMYLOIDOSIS
A.Poulopoelos, Fl.Sotsinu, Or.Vosnides, N.Nikolopoulou,
L.Narinos, H.Margellos, Tn.Apostolou, D.Sadjiyanna-kos,
D. beorgatnpool no, A. Hill's
Division of Neprhology and Department of Pathology,
Evaogelismos Hospital, Athens, Greece
it is widely believed (1,2) that rectal biopsy is positive
for amyloid in 70—P57. of patients iptsl with systemic
amyloidosis, primary or secondary, but there are doubts
whether this high persentage is actually observed in
everyday practice. Therefnre,we studied retrospectively 13
pts 17 men,6 women),41—74 years old, who were hospitalized
from 1978 to 1989 for systemic amylnidosis Iprimary 6,
secondary 6, familial I) and who, at the same period,
underwent rectal and percutaneous renal biopsy.All pts had
clinica.l and laboratory indications of renal involvement
19 nephrotic syndrome, 3 acute renal failure and 1 chronic
renal failure). Rectal tissue contained submucosa in 5 out
of 10 pts for whom retrospective study of the biopsy
material was possible. The renal biopsy specimen was
diagnostically adequate in all pts. both specimens were
studied with the standard methods )hematosyline—eosine.
Congo red and crystalline violet). Renal biopsy was
amyloid—positive in all pts, while rectal biopsy was
amyloid—positive in only two pts 115,37.) with Secondary
amylnidosis. In one of these pts. the rectal biopsy
material contained submucosa.
Our observations: 1) Confirm the diagnostic value of
renal biopsy in systemic amyloidosis, primary or
secondary. 2) Indicate that rectal biopsy is negative in a
high proportion of patients with amyloidosis, especially
primary, and that this occurs even if the specimen
contains submucosa.
l.bafni & Sohar 1960. 2. Kyle et al 1966.
NEFHROTIC SYNDRO)fE Ii THU IIUTIFL RbINILEITPTION UP CIRHETES
MELLITUI
bohr. 3. Pspadskis, Fl. iotsiou, U. Fiessadias, K. Sacciv,
H. Lymperopculos end N.H. Pepadodimes.
Renal Unit
Izanion Denerni Hospital, Ficeeos, Oreece.
Oishetic gioserulonephritis constitutes one of the major
causes of nephrotic syndrome in the sdult in sost pmtients
It develops after several years of documented glucose into-
lerance and coexists with ceti000sthy. Renal symptoms coos—
sionsly sppeere in petients without prvclously known diabe-
tes mellitus (OM).
lie present 3 patients with nephrotic syndrome without any
manifestation of OM, who vere submitted to canal biopsy
end had the pathologic lesions of dietetic glomerulssclero—
sis. 5)1 patients vere men, eged sore than 55 yeras old,
without any sedicel or family history of renal disease or
OM'fasttng plasma glucose was less then 110 sg/dl several
tises and fundoscopic exaslnution revealed no evIdence of
dietetic retinopathy. iwo patients presented stth pedal
edema end mild renal failure (OFR 57 end 53 al/sin). The
other presented vith generalised edema, serum creatinine
S mg/dl and started immediately heemodielysis. Rglurcse to-
lerance test yes performed in all patients after the histo—
logic diagnosis of diabetic glomerulopathy yes established.
The test was dIagnostic of OM for two patients, including
the patient in dialysis, end revealed Impaired glucose to-
lerance for the third.
Nephrotlo syndrome end renal failure may presents as the
first symptoms of DM questioning thus the concept that die-
tetic mlcroangiopathy is dependent exclusively on the dura-
tion of hyperglucemie. Renal biopsy is necessary to este—
hlish the correct diagnosis In these cases.
THROMBOEMBOLIC EPISODES IN PATIENTS WITH IDIOPATHIC
MEMBRANOOS GLOMERULONEPHRITIS (IMSNI AND
NEPHROTIC SYNDROME
N.Nikolopoulou, D.Hadjiyannafcos, M.Siakotos, A.Poulnpoulos,
6.Stavianoudakis, J.Malegos, B.Margellos, N.Tsianas,
M.tavros, P.Mangana, A.Billis.
Division of Nephrology, Evangelismos Hospital,
Athens, Greece
The incidence of the thromboembolic episodes (TEl and their
treatment was studied prospectively in 73 patients (ptml,17
to 74 years old, with IMGN and riephrotic syndrome Who were
followed—up during the 1979—89 decade. Six pts had
initially impaired renal function Iserum creatinine 1,4—3,0
mg%). In 45 pts, including all those with TE, renal
venography was performed by retrograde catheterization of
the femoa-al vein. A total of 23 TE were diagnosed in 15 pts
(20,SXl.Renal vein thrombosis (RVT) was radiologically
revealed in 10/45 pts (22%) and in 5 of them was bilateral,
although only 3/10 pts had a compatible clinical picture
(hematuria and/or renal painl.The remaining TE (7 episodes
of thrombosis of the lower limb veins and 6 of pulmonary
embolism) occurred in 11 pts (6 with RYT and 5 without
RVT). All pts with TE received anticoagulants (initially
heparin followed by warfarin) for at least one year. No
further TE were seen while the pts were on anticoagulant
treatment ( although the nephrotic syndrome persisted in
13/15 pts I and,after its discoeitinuation,there was only
one episode of pulmonary embolism which was dealt with,
successfully. The only wide—effect of treatment was one
case of macroscopic hematuria. At the end of the follow—up
period (3 to 123,mean 57,6 months) 6/10 pts (607.1 with RVT,
including all 5 with bilateral RYT, 12/35 pts (34%) without
R'IT and 5/28 pts (18%) who had not been studied by
venography,had renal failure or had been put on
hemndialysis.
In conclusion: a) TE were seen in one fifth of the pts, RYT
being the most frequent and usually asymptomatic, blthe
anticoagulant treatment was safe and effective in
preventing new Tb, cI bilateral RYT contributed to the
development of chronic renal failure.
FRIQiINCY IF If I 000Ilil HISTILIGIC FIRMS IF IllIPlIf IC GLlMlfuLlPATf 115 If
IHI IISTRICT IF CfffflA, CMIII, lRllCl. THE CLIHIIAL CIIRSE.
Papadakis,l., Virvidakis, K,, lideras, S., Kagia, S., Kiuflaki, N. cii
lubiilakis, I.
Renal unit, Sen. fisp. if Chania.
In the district if Chavia, Crete, Sreece, with 121.1(0 Inhabitans, we studied
the freqiency if the variiis histiligic fires if idiipathic gliserulipathies
ISP) and their clinical eeilutiin in 34 )lreek pts, diring the decade (ne
3I/i/79 until 3l/i/l9.
21 were sale aid 14 fe.sle, with ccci age 34,4 and 49,3 yeare, whi inierweit
renal hiipsy. Renal tissie was esawined, in all patients, hy light aicniscipy,
iceunifluirescence aid whenever cinsidered necessarf by electrin wicriscipy.
The clinical presentatiin if IP was sy.ptieless priteinuria ani/ir hweeatunia
iv lB pts 5311 which ivcluded 3 with wacniscipic haewatiria, nephritic
syidriwe in 15 pts (441) and acute nephritic syvdriae in inc. Renal fuctiiv
was nireal in 29 plc with sane creativine 1,4 eq 1 aid iapaired in 5 with
s.cr. 1,1—4,5 sq I.
The wist frequent histiligic fires if idiipathic SF were, eesangial
priliferative SF (II pts — 531), which ivcluded 7 pts with IgA - vwphnipathy
20,51) end ive with 1gM nephripathy, and aewbranius SF II pts - 23,51).
The ither fires if SF were itwerved less frequently.
feebransus iephnspathy sac the eist frequent 1411) cause if nephnitic
syvdri.e.
At the end if the filliw up pefiid, 14 pts 1411) were in cieplete clinical
reeissiii, I ph 2311 had asyptiestic priteinuria muir hieeaturia eith 5cr
I 1,4 aql, i phi Ill) were in chrinic renal failure with s,cr 1,9—5,3 egl and
S pts (III) were in chrinic heeidialysis.
MURINE MONOCLONAL LUPUB ANTI—DNA AUTDAIITIBDDIEB
PENETRATE CERLB IN VITO, BIND TO NUCLEI AND INDUCE
ULOMERULAR PROLIFERATION AND PROTEINURIA.
D.V. Vlahakos, N.H. Foster, A. Ucci, IC.J. Barrett
and H.P. Madam
New England Medical Center, Boston, Mass., USA
A subset of individuals with lupus and other
autoimmune disorders have IgU nuclear deposits in cells
of skin, blood vessels and kidneys. It was previously
found that polyclonal IgU anti—nRNP autoantibodies
penetrated into living mononuclear cells, in vitro, and
produced functional abnormalities. To further
investigate this phenomenon, in vivo, sonoclonal anti—DNA
antibodies, derived from lupua—prone MRL—lpr/lpr mice
were administered to normal mice. 20 anti—DNA antibodies
were selected on the basis of cross—reactivity with
multiple autoantigens. Following administration, the
kidneys and other organs were analyzed histologically,
and urine protein excretion was determined.
Three anti—DNA antibodies (N7,N9,H72) bound nuclei
in vivo. This nuclear binding was not confined to the
kidney; it was observed in liver, spleen and heart.
Furtheraore it was associated with glomerular prolifera-
tion and proteinuria. The results are summarised below:
iaAb(clsss) 117(01) M9(02A) 872(01) #M73(C2B)
p1 7.5—8.0 8.6—9.2 7.5—8.0 7.7—8.2
Upr(mglday) R.O+1.l' 1.11+0.2' 1.3±0.1' 0.67+0.11
Nuclei/gb 37+1' 38±1' 113±1' 31±1
'P<D.DS #Contrcl mAb (no immune deposits)
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PRESYMPTOMATIC DIAGNOSIS OF RENAL POLYCYSTIC DISEASE (RPD)
A. Agrafiotis, P. Girkinoudis, 0. Papadopoulou,
N. Papadimitricu, Gr. Vosnides, D. Loucopoulos
1st Pathol. Clinic of Univ. of Athens and Divisions of
Nephrology of Laiko Gen. Hospital of Athens and Ag. Sofia
of Salonics
The detection of the RPD gene is nowdays possible due to
its linkage with neighbouring recognizable "nameless" DNA
regions on the short arm of chromosome 16. These regions
are quite close to the RPD gene and are genetically trans-
mitted with it. Recognition of these regions are possible
with the use of special DNA detectors. The detectors used
in the present study can pinpoint one polymorphic region
located to the left and one located to the right of the RPD
gene.
The present study was undertaken in g families In which at
least one member had RPD. In 3 of these families the search
for the DNA detectors wan done in members of 3 successive
generations-and the other 6 in members of 3 generations. A
total of 50 persons were examined, of which, ig were known
to have RPD which correlated with the specific DNA locations
In 9 persons aged 12—38 yrs the specific DNA locations were
recognized despite any clinical evidence of RPD. According
to genetics these people are expected to express the disease.
In 18 other persons aged g-32 yrs the RPD gene was not found
which means that these people are not going to develop RPD.
It is concluded that in families with RPD,recognition of the
"DNA detectors" allows early preclinical and regardless of
age recognition of those oersons who are going to develop
the disease.
187
In summary, selected ourine moncolonal lupuo anti—
DNA autoantibodies penetrate cello, in vivo, and bind to
nuclei. This process is associated with glomerular
proliferation and prcteinuria. Both the mechanism of
cellular penetration and the clinical significance of
nuclear deposition in the pathogenesis of lupus are
currently under investigation.
THE EFF'ECT OF DAILY SODIUM INTAKE ON CALCIUM LEVELS IN
ESSENTIAL HYPERTENSION
A.N. Lassridio, K. Hatzitoannou, H. Dedusi, P. Crammaticos,
C. Kaixis, A. Sofas, P. Zeabekskis, A. Tourkantnnis
First Dept. of Medicine, .5.IIEPA University Hospital,
Thessaloniki
There is evidence that patients with essential hy-
pertension excrete sore urinary calcium and that low renin
hypertenaivea have lower serum icniced calcium (iCe). In
view of the close interdependence of Mm—Ce fluxes, the sta-
tus of Cs was studied under varying sodium intmke in 18 pa-
tients (10 male) aged 47.3 year (30—64) with mild essential
hypertension. Ihe patients were given e constant diet with50 mmol Nm per day for 5 days end then with 200mmol Na per
day f or additional 5 deys. Calcium daily intake mpproxioe—
ted the 1 gr. all over the trial. Serum and urinary electro-
lytes were eeeeured every day end effective renal plasma
flow (EKPF) end plasma renin activity (PRA) were estimated
the 5th day of emch diet period by orthoiodohippurmte end
KIA respectively. The change of Ma intake from 50 to 200
meal resulted in: Increase in ERPF from 562.8±30.6 to 692.8
+37.2 al/mm (meen±SRAl, p<O.0O1). Decrease in iCa from
1.046±0.02 to 0.980±0.04 mmcl/l (p<O.05). The urinary Ce
excretion (0Cm) increased fran 179.2±26.5 to 386.6±86.9 mgI
24h (p<0.C5) and the urinary Celcium/Crestinine ratio (Ce!
Cr( frnr 0.106±0.009 to 0.212±0.032 (p<0.O1). Changes in
celciuresie were positevely related to changes in netriure—
eis (r=0.57, p<0.05) end chengee in Ce/Cr to changes in
ERPF (r=U.46, p—=0.05). Low renin patients and older patients
showed e lesser increase of celciuresis between the two pe-
riods (ACe/Cr v. PRA r=0.72 p<U.OO1 end AUC5 v. age r=—0.61
p<0.01). The Ce/Me in the urine was lower in low renin pa-
tients (r=0.60 p<0.U1). Serum iCe wee lower in low renin
patients in both penlode. It is concluded that lower iCe is
nnt caused by higher celciuresis end thet calciureeis is
rather influencend by ERFF.
CHRONIC RENAL FAILURE (CRF) AND LIPID! PARAMETERS
A. Dova, K. Karanikas, K. Karvcunis, A. Karaouzas
2nd Department of Internal Medicine of District
General Hospital of Larisa, Greece
Patients with CRF xhow frequently evident signs of atheros—
agy was to elucidate the potential disturban-
ces of serum lipid parameters levels in petsanta alth CII'.
Meteriel—Methods Thirty ambulatory patients aged 3D—7Oyeers,
with 088 of different greatinine clearance (30 Mt/I'-5 Ml/I'laere
stiedied.In.these patients serum levels of total choleNterol,trii.giycerioes,LDL ano MNL were Neasured.Patients wicnr±1ro-
tic syndrgap diabetee mellitus liver disease and know histszy
of hyparlipibemia,were excludeb.Results:The results of the study are contaared na lie table.
Material Meter total dolaminol mig1caddo bIlL MDL
>220l4gr% >1SO?.tgr% >16014gr% <55 ltr%
Men 15 l0(66,6%l 12180%) ul73,il 9l&l
women 15 11173,3%) 13186,6%) 10166,6%18153,3%l




lipid changes coul8 be observed in normotansiveas well as in nypartenaive patients.
Conclusions:IlAlready.ip early stages uf CR8 basic chagges
ut levels in plasma lipid parameters may be observed lincrea—
cv of tutal 2holesterol,Triglycerides,LNL levels and thcceame
of HDL levels).
2)These serum lipid alteration levels may contribute to
premature atherosclerosis observed in patients with CR8.
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LOW DENSITY LIPOPROTEINS(LDL)FROM HEALTHY HUMANS AND CHRONIC
RENAL FAILURE(CRF)PATIENTS BINDING BY RAT MESANGIAL CELLS
(RMC)AND HUMAN FIBROBLASTS
S. Efstratiadis, R. Fernando, Z. Varghese, M. Gillett,
3. F. Moorhead
Department of Nephrology and Transplantation Royal Free
Hospital Hampatead London
L.DL from healthy normoliqideemic humans and CRF
patienta (under renal replacement therapy or not) mere
iaolated by centrifugation. Both of them mere radiolebeled
by enzymatic iodination mith 1251. Six samples from each
LDL group mere produced, with similar final volume (1,2
ml) and diffejent concentrations. Each of the samples maa
mixed with 3 generation rat mesangial cell culture waterial
in the space of the calture wells. These cultures were
produced from renal cortex fragments of 140-200 g masculineS.D. rats.
The experiwente were performed in 40 C for 4 hours
and after this binding time they were washed by 8 consequent
washes with buffered saline. The final sewple solution was
produced by adding 1 wI of NeDH and after one hour the
radioactivity of the samples was eatiwsted by a y-counter
and the protein concentration was weaaurod by using the
Lowry wethoth Exactly the aawe procedure was performed
aiwultanously by uaing human foreskin fibroblaats instead
of wesangial cells.
There waa a significant correlation between the LDL
binding level and the LDL concentrations in both LDL groups
and in both cell cultures.
There were no aignificent differoncea in binding curves
between the two Kinds of cell cultures. The binding curve
of LDL frow healthy humans won significatly higher then
the curve of CRF patients.
Conclusions: I. There ia an evidence that rat wesangial
celia contain huwan LDL receptors.
2. LDL binding is lower in CRF patients and maybe
that is why they could be wore atherogenetic.
PREDICTION OF THE PROGRESS OF CHRONIC RENAL FAILURL AND CO-
AFFECTING FACTORS
S. Spaia, K. Mavrometidis, F. Christidcu, N. Zoumbaridis, F.
Solonaki, K. Baltatzi, G. Vaynnan.
Nephrnlogic Clinic, Second Hospital of I.K.A. Thessaloniki,
Greece
Is order to estimate the progress of chronic renal failare
(C.R.F),we resiewed the date of 54 pts admitted to our Cli -
nic with C.R.F. during the last 7½ years and finally requir-
ed dialysis support. The primary disease was glomerulonephri—
tis (78%), pyelonephritin (13%), various in the rest 9%. The
pts were divided is four groaps according to creatinine cle-
arance (CLcr). Group A: 10 pts, mean age 53 y., CLUr 30-50
ml/min, duration of observation 53 months(mean value). Group
8: 19 pts, mean age 55 y., CLcr 20—30 ml/min, observation 41
months. Groap C: 13 pts, mean age 58y., CLcr 15—2Oml/min, ob-
servation 35 months. Groap Do' 12 pts, oean age 51 y. , CLcr un-
der 15 ml/min, observation 21 months. We determined the re-
lationship between the progress to end stage renal disease
and the cause of renal disease, age, serum creatinine, CLcr,
BUN/serum creatinine, the frequency of the follow—ups, the
presence of hypertension and preteinuria. Statistic analysis
wan run out using t—test, crosstabulation and regression
analysis. We found a strong correlation of the duration of
the observation to the initial serum creatinine, the BUN/se-
rum creatinine and pretninuria (p<O.OS). Prediction of the
duration of the observation can be obtained by the means of
seruv creatinine (r2±'O.63).
It in concluded that, Progress of C.R.F. depends on serum
creatinine, on DUN/serum creatinine and on the presence of
proteinsrie. Primary disease does not affect the progress
of C.R.F. when initial clearance creatinine in under 4Oml/min.
Hypertension and acute dntmrioretions in renal function do
not alter the progress of the disease, if they are sufficient-
ly handled. Medical consultation every two or three months
seems to be adequate in patients with C.R.F.
FUMOR MARKERS IN PATItNFS UNDFHGOING HFMODIALT%IS (HO) ANO
KIDNEY TRANSPLANTATION 1Tv).
N.7eferov, 0. F .Oiqenie, H. [hr ivtophureks, U .Alevopeuloe,
F.Cyftvki vnd T.Moulepoulov.
Oislysie unit sod Nuclear Medicine depvrtveot, Therapeutic
Olieie, Athees University Medicul School.
AtM, [A19—9 )0.I.trvef), [A125 )oevrieu) sod [A15—3
(hreast) yore nesnured by RTA so 51 hevithy controls (0),
23 urenicv undergoing HO for 46±7.2 so )s±SFH) snd 30 trsnn—
pleeted indieiduvle vith v functioning renal graft for 42±
3,5 no. None of thee shoved soy eynptemv or signs of neo-
plvsia. AtM, [FA sod [Al5—3 leeds vere siqoifirsetly hig-
her in HO sod Is groups shen cuepsred to the 0 group,vhiln
[A19—9 sod [A125 ealues did not differ smoog sIT groups.
AtM [FA [A19—9 [A125 [A15—3
O 0,92±0,2 2,2±0,1 15,8±1,0 19,7±1,3 12,8±0,4
HO 8,5 ±0,6 14,5±2,3 20,0±2,5 16,2±0,8
Tv 3,4 2,8±0,2 20,9±4,0 23,8±3,8 22,9±1,8
The Is group hsd significantly lover AtM aod OFA but hig-
her [Al5—3 leeds, uhee ronpared To the HO group. There
use no correlstioo betvnen the flee oo HO or Is and the
leeels uf soy fuser earker. These results lead to the
foliseing roerluaioes:a. Ohs reduction of AtM sod Ic—
eels folloeioq Is suggests a possible sot ice role of fun-
ctioning reeal tissue Ic fhesr elssinstiuo. b. CAl9—9 and
0A125 can be cocssdered as relsuble tueor esrkers in pta
uederqoiog HO or Is. c. The etiology of raised [A15—3 le—
eels so the Ts group should be further eeslusfed.
TUMOUR MARKERS IN RAEMODIALYSIS PATIENTS
1). Toakiris, I. Gcorgakopoulou, C. Vissardis, A. Keleoidio, T. N; soche,
3. Liatois, M. Papadimitriou
Renal Unit, Ariototelican University, and Department af
M icrebiolegy, I lippokratean hospital, Thesseloniki
We studied serum carginoembryonie antigen ICEAI and a-fetopratein
IAFPI levels in T9 haemodialyais patients (HDI without clinical
evidence of neoplasia 152 men, 27 woman with mean age 49 years and
mean duration of haemodialyois 48 monthsl using a monoelonal
enzymatic essay in order to assess the diagnostic significance of these
tumour markers. CEA end APP levels were also msasore& in 311
patients with primary hepatoma and 20 patients with cirrhosis.
CEA elevation (>le ng/mLl was observed in 11% of HD patients (9 of
791, in 17% of the patients with hepatoma (5 of 3e), and in none of the
cirrhosis patients. Non-smokers RD patients had in an even higher
proportion eleeated serum CEA levels (32%, 18 of 54 patients)
compared to smokers (12%, 3 of 28 patiento). Mean CEA leeds in the
oserell I-ID patients were not significantly different from those in
hepetoma patiento (6.9±0.8 Rn 15.9±27, NS). APP lescin were
abnormal only in one LID patient (1%). in 12 hepatoma patients )4e°AU,
and in 3 patients with cirrhosis (15%). Oeerall mean APP levels were
significantly higher in the hepatoma and cirrhosio patients compared
to RD patiento (197±35 no 3.0±2, p.00.001 and 113±25 eo 3.0±0.2,
p<O.OOl reopeetivelyt
In conclusion , CEA leeds in lID patients are increased to leeds
comparable to those of cancer patiento and have little diagnootie
value, whereeo APP leeds remain within normal levels. These results
moot he taken into account when esaloating RD patients for
neoplaoia.
A MULTICENTER STUDY FOR THE CLINICAL EVALUATION OF
PAIRED FILTRATION DIALYSIS (P.F.D.)
A. Diamedopoulos, E. Hinary, K. Kalitzidis
Renal Unit ,"St. Andreus" ,Regional Patras Hospital
The aim of our study was the clinical evaluation of P.F.D. 123
patients who were on P.F.D. from 2 months till 4 years were in-
cluded in the study. They have been treated in 24 Dialysis Centers
in Greece and Italy. A Guestionaire was sent to the heads of the
units,snd the writers also visited several centers in both countries.
The questions and the corresponding answers were in brief as fol-
low:
A) Reasons for starting patients on P.F.D.:
Cardiovascular problems (43.5%), scientific interest (33.3%),shor—
ter dialysis hours (23.4%) and also anemia, anorexia, bone aches,
prutitus and cramps in a smaller proportion.
B) The cardiovascular problems were improved in 90% of the pa-
tients and the rest of the symptoms from 44.4% to 75% in both
countries.
C) However in Greece 03% of the patients returned to haemodia—
lysis, mainly because of water imbalance, refusal of the patients
and inadequate A-V fistula.Thispercentagein Italy was only 15.5%
(P<0.O0l).
D) The blood flow during dialysis in Greece was 220 50 mi/mm and
in Italy 330 50 ml/min. In Greece the substitution fluid was Rin-
gers solution (72%) or solution for HF (28%) at an infusion rate of
1—1.5 It/h. In Italy the substitution was Lactate solution or HF so-
lution with bicarbonate at a rste of 3 lt/h.
We conclude that the method gives very good results only in well
experienced hands with a sound theoretical knowledge.
EVALUATION OF DIALYSIS INDEX COMPARISON OF FOUR
DIFFERENT METHODS.
N. Zoumbaridis, Oh. Fitili, K. Mavrosatidis, N. Dombros,
A. Karagianni, K. Sombolos.
Abs tracts
Renal Unit, "0. Papanikolaou" General Hospital., Thessaloniki
Dialysis index "K.T/V", 1K = dialyser urea clearance, T =
dialysis time, V = ures distribution volume) was calculated
by the direct quantification method lOOM), after a complete
collection of dialysate, in 16 hemodialysie sessions. Under
the same dialysis conditions at intervals greater than one
month two measurements were performed in 7 chronic dialysis
patients and a single one in two additional patients.
In each patient the DOll value was considered as "standard"
and compared with 3 other values 1019, OIL, 0101, obtained
by the following methods a) 010, by Barth's equation, bI
OIL, by the equation loglUi/U21, where Ul and U2 urea befo-
re and after hemodialysis and ci 010, using a microcomputer
software (Compumod, Urea Kinetic Software, Version 2.41.
The mean values + SD for each of the indices were, 0DM
= 1.19 0.19, 010 '±1.10 0.10, OIL = 1.00 0.12 and 010
= 1.16 + 0.15.
A high degree of correlétion lrtm = coefficient determina-
tion) was found between 0DM and 010, r2 = 0.98, whereas OIL
rZ = 0.70, and DIG, rZ 0.50, correlated with 0DM to a
lesser degree. The paired 0DM values in the 7 patients were
1.22 0.09 and 1.19 0.29, )Wilcoxon matched—pairs signed
ranks test, pw.}.61).
It is concluded that a) dialysis indes calculated by
Barth's equation 1010) has a better correlation with 0DM
b) its value appears to be 9 7. lower than 0DM and ci in
the separate but similar dialysis conditions 0DM does not
differ in the same patient.
COMPARATIVE STUDY BETUEEN LOW MOLECULAR WEIGHT AND UNFRAC-
TIONATED HEPARIN IN HEMODIALYSIS
D.Staoatiadis, E.Hatzaki, Ch.Stathakis, A.Tsoukala, D.Gou—
memos, A.Lsgourenis, E.Fragou, A.Kremasmenou, T.Mandalaki,
snd Gr.Vosnides.
Division df Tiephrology and 2nd Reg.Blood Transfusion Cen-
tre, Laiko Genersl Mospital — Athens — Greece.
The sim of the present prospective study was to compare
the efficacy and biocompatibility of the 'classical' un—
fractionated heparin (UFH) with the "newer" low molecular
weight heperin (LMWH) in HO. For this, 6 pts undergoing HO
with hollow fiber cuprophan dialyzers for at least 6 months
were dialyzed for 10-25 sessions with LMWH followed by ig—
20 sessions with UFH. During the study, extracorporeal cir—
quit thrombosis (semiquantitatively assessed)and post HO
pressure time for hemostasis of the A—V Fistula were recor-
ded for all sessions. Also, for each pt, platelet counts,
platelet factor 4, sctivated psrtial thronboplastin time
(APTT) were determined and, platelet aggregation (ADP and
collagen induced) and adhesiveness tests were performed,
immediately prior to and after the 4th and 16th MO session,
with each type of heperin. The results obtained showed
that: I) UFH significantly prolonged APTT (p40,01) but it
inproved significantly (p40.05) platelet aggregation and
adhesiveness tests. 2) A-V Fistula henostasis time was sig-
nificantly estended (p<0.01) with LHWH in 1 pt only. 3)
Extracorporeal cirquit thrombosis was significantly higher
(p <0.01) with LHWM in 1 pt only. 4) In contrast to UFH, a
single IV bolus injection of LMWH was sufficient for HO
sessions of up to 4 hours duration. 5) Two serious allergic
reactions occurred with UF)) in 1 pt. The results of our
study show that neither type of heparin is superior to the
other and that, apart froo the relative ease of use of LMWH
for "short" ( é 4 hrs) HO sessions, anaphylaxis to UFN may
be the only major indication forthe application of LMWH
in XD.
LOW MOLECULAR WEIGHT HEPARIN VERSUS UNFRACTIONATED HEPARIN
IN HEMOOIALYSIS. INFLUENCE ON PARAMETERS OF HEMOSTATIC
MECHANISMS.
Eravaritis A., Papadakis ,l., Polychronaki E., Tsoukala A.,
Patrikarea A., Makriniotou J. , Liapi S. and Mandalaki T.
Renal Unit of NIMTS Hospital and 2nd Peripheral Centre of
Blood Transfusion, Laiko General Hospital, Athens, Greece
We studied the influence of a low molecularweight heparin
(LMWH) on hemostatic factors during hemodialysis and in com-
parison to unfractionated heparin (OH). In ig patients, 11
men and 8 women, mean age 53,4±15,7 year old, who have been
undergoing hemodialysis thrice weekly for 4 hours each time
we measured before (a), at the end (b) and after 24 hours
(c), the following hemostatic systems: 1)the patrial thrombo—
plastine time (5PTT), 2)the normal coagulation inhibitors:
antithrombine III (AIrI) and protein C, 3)the fibrinolytic
system: enspherine lysis time (ECLT), plasminogen (PLG),oi—
antiplasmine (o2-snt) and D—Dimer, 4)the probable platelets
activation: PF4 and 31G. S)the Von. Willebrand factor. The OH
and LMWH were administrated in necessary to avoid thrombosis
doses 10—15.000 IU and 15-22.500 IU respectively. From the
initial value a change was found (t pair test) with the LMWM
in: PF,: a:16,7±8, b:28,4±18 (p<O,02), in ECLT: a:458,5±30,8
b:401±44,4 (pcO,Oi) and in PLG: a:l06,5±16, b:llS,6±l7,3, c:
111,8±15,2 e.g. a-b:pcO,01, a-c:p<O,Oi. With the UH: in PF4:
a:12,2±6,g, b:27,g±18,7, c:2g,5±23,4 e.g. a—b:p.cO,Ol, a—c:
pcO,Ol, in aPTT: a:41,l±9,71, C252,6±ll,i (pcO,Dl), in ECLT:
a:396±7g,1, b:31l±83,6 (pcO,Ol) and in o2-ant: a:103,3±l1,g,
b:124,2±16,2 (i<0,05). No differences were foundinthe rest
parameters. Comparing the two heparins differenceswere found
in PF4 where the increase was prolonged during UM admini-
stration O,OS>p>O,Ol and in aPTT where the change was very
significant p<O,001 after 24 hours.
Conclusions: l)Both anticoagulants satisfactory prevent
the thrombosis during hemodialysis, 2) the use of LMWH pre-
vents further hemorrhagic manifestations and it is suggested
in patients with risks of hemorrhaqe.
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SODIUM SINSITIVITY IN NORMAL RENIN FSSI2±TIAL HYPERIERRION.
£. PER—CS SODIUM AIHoNISTRATION
M.D. Papagalanis, A.V. Karabatsos, P. Skopelitis, 3. Saklaridis,
Ceorgia Kostogianni, Angela Rourti, Maria Cennadiou and
Th. Houndokalakis. Dept. of Nephrology Red Cross Hospital of
Athens. 2nd Dept. of Intern. Medicine Univer. of Athens. Dept.
of Polykliniki Hospital of Athens.
In order to determine the rate of sodium excreccion in normal
renin essential hypertension, after voluse expansion, 11 hyper-
tensive and 7 norsotensive people. With negative familly history
of hypertension. Were shifted from ssiderate (50 mP±/24h) sodium
intake in which they ware for 8 days (1st period) to a. high so—
diijxs intake (310 mEq/24h) for another 8 days (2nd period). In 7
hypertensives (HPI) MBP increased sore than the increase plus
250 of the noniotensives (N) by the end of the 2nd period. These
HPj had lower Clpan than Na of the end of either 1st (508, it
20,7 mi/san vs 564,1±23,1 mi/san p< 905) and 2nd period (529,7±
17,6 ml/sdn vs 581,0±21,0 mi/san, p<O,00S) and higher FR' (0,1845
vs 0,1776±0,002 p<O,001 in the 1st period and 0, 1823±
0,003 vs 0,1707±0,0016 p<0,04 in the 2nd period). FlI±a-4- was not
different in the NPI, N, and in the remaining 4 HP )HPII) during
the 1st period tot it was significantly lower in Nfl than in N
(0,94±0,14% vs 1,94f0,11%, pCO,00l) and in PHIl (1,74±0,08 p<
0,001) by the end of the 2nd and in HPII (1,74±0,08 p<O,00l) by
the end of the 2nd period. The increase of ItIja was correlated
to beth reduction of PP (r=0,88, p<0,00l) and PRA (r—0,77, p<
0,001) during the 2nd period of the study. PRA was 1,54±0,23 ng/
mi/h in N, 1,54±0,09 ng/mi/h in ERr and 2,0±0,26 ng/ml/h in NPn
before high sodium intake. At the end of the 2nd period, PIA was
0,59±0,053 ng/s,l/h, 0,85±0,16 ng/ml/h (p<O,Ol) and 0,7 ng/
mi/h in N, HPI and HPII respectivefly. Renal function carve was
shifted to the right in beth FRI and NAIl (x—intercept: 96,7±1,21
smHg, 129,1±3,7 sisNg p<0,001, and 112,4±5,86 msHg, p<O,O5 in N,
FRI and HPII respectively) but the reciprocal of the slope b was
higher only in HPI/0,1256±0,017 smiH/ (mRq/24h) vs 0,004±0,0±06
smllg/(mEq/24h) p<O,00I in N, and 0,0059±0,005 msHg/Iiwag/24hI, p<
0,001 in HPII. The 1/b was negatively correllated to the 1st
periodss PER (r=0,83, p<O,O5 in N, r—0,82, p<0,05 in HAl end
r=-0,81 in NPIj) and to the decrease of PER by the end of 2nd
period (r—0,878, p<0,00l). These results indicate that sodium
sensitivity of the patients of this study man be related to
the inapropriate Renin supresion and inapropriate of ASK after
extracellular vol±sie expansion.
ThE flE OF ARGININE-VASOPRF.SIHE AND OF FILTERTIQI FRACI'ICR± IN
ThE OEF0XTIVE FREE WATER CLEARANCE IN PATIENTS WITS D4PRNSA0'RD
CIRRNODIS.
14.0. Papegalanis, L.I. Floros, P. Skopelitis, 2. Saklaridis, G.I.
Kostogianni, M. Gennadiou, H. Papenilcolaou and Th. Meuntokalakja.
2nd Dept. of Internal Medicine, Univ. of Athens, 2nd Dept. of
Internal Medicin General Hospital of Athens, Hephrology Dept. Red
Cross Hospital of Athens and Dept. of Biochemistry PolykliniJcis
Hospital of Athens).
Twelve cirrhotic patients with askites and five healthy volunteers
(control group) received a 20 mi/kg water load. Seven of the pa-
tients (excretors) and the control subjects excreted oniarable
asounts of water in 3h (67,24±1R,06% and 50,91±14,1% of the water
load respectively) and achieved a]aost the sase minimal urine os-
molality. (130,0±25,13 xslsis/Kg and 130,0±20,0 mOms/Kg of control
group and excretors respectively). The resaining five patients(non-excreters) excreted only 18,87±8,4% of the water load in 3h
and the minimal Ones recotded was 502,0±91,lS-sosmjkg, (pCO,00l).
Plasma Ave concentration was 1,32±2,0 pg/mi in control group, 1,6±
0,07 pg/mi in excretors and 2,3±0,25 pg/mi (p<0,05) in non gxcre—
tors. Free water clearance was 2,6±0,69 mi/min, 1,41±0,52 mi/min
and —0,55±0, 32 mi/min (p10,001) for the control group, the excre—
tors and the non excretors respectively. Healthy people had Chin
120,7±4,27 mi/min, excretors had 94,87±2,48 mi/min and non excre—
ters 79,72±4,4 mi/mm (p<O,001). ClpM was also lower (350,7±19,1
mi/min p10,001) in non excretors than in excretors (454,32±27,14
mi/mm) and in healthy subjects (584,7±29,5 mi/min). An effectiveblood vol±me lower in non excreters than in excretors was sugges-
ted by a lower plamsa albumin (2,74±0,10 versus 3,086±0,29 gr%,
pCO,0l) a higher PER (4,7±2,45 versus 1,56±0,54 ng/mi/h and a
lower urinary soditas excretion (3,05±1,07 versus 22,6±8,1 slKg/24h,p<0, 001). Although plasse AW concentration was significantly
higher (p<O, 001) in non excretos-s than in excretors for the ease
level of plasma ossolality, free water clearance was found to be
sore FR-dependent )r=—Q,64, pCO,05) than AVP-dependent (r=—0,36).
These results suggest that renal hesodynamic factors are sore
important than AW levels in determining free water clearance in
patients with deosipensated cirrhosis.
Abstracts
SODIUM SENSITIVITY IN NORMAL R8I4IH ES5ONTIAL NYPEICR24SICN.
II. INTRAVS3IOVS SODIl04 AIO4IHISTRATII±i.
M.D. Rapagalan±s, A.V. Karabatsos, P. skopelitis, Ceorg±a Kosto—
gianni, Angela Kourti, Maria Cennadiou and Th. Z4iuntokalak±s.
Dept. of Hephrology Red Cross Hospital of Athens. 2nd Dept. of
Intern. Medicine Univer. of Athens. Dept. of Biochemistry noly-
kliniici Hospital of Athens.
In order to determine the rate of sodium excretion after a
small sodium load in normal renin essential hypertensives wIsa are
in high sodium balance, 62 mKg Hal- were given IV as Had 9% in
60' to 11 hypertensive and 7 noesotensive people who were in a
350 aEq/24 h sodium intake for 8 days. In on line and PAN clea-
raites as welt as fractional excretion of sodium (FSea+) were de-
termine during the 15th leers post infusion. PER was determined
isediately before and 1 and 2 hours post Infusion.
In 7 hypertemsivea (FRr) M5P increased sore than the increase
plus 250 of Norsotens±ves (N) and the remaining 4 hypertensives
(FRII). F004a was 1,81±0,12% in N, and 1,71±0,04% in NPII, but
only 1,06±0,1% )pCO,00l) in FRI. These FRI had a FR 0,187±0,028
VS 0,169±0,003 (p10,501) of N and 0,18±0,0013 (pCO,00l) of FRfl.
PBS was 0,66±0,019 ng/mi/h in N, 0,86±0,14 ng/ml/h in FRI and
0,74±0,0088 mg/mi/h in NAIl before saline infusion, and 0,46±
0,024 mg/mi/h, 0,79±0,129 mg/mi/h (pc0,05) and 0,59±0,068 mg/mi/h
in N, FRI and NAIl respectively 1 h pest infusion, and 0,91±0,015
ng/mi/h, 0,82±0, 13 ng/ml/h (pc5,05) and 0,04±0,04 ng/mi/h 2h pest
infusion. The increase of FENas. was corellated to beth oFF (re
0,88, p-C0,50l) and PM (r=0,77, pCS,00l) during the 2nd period,
but only to the ORBS (r=0,77, pIO,Ol, and pCO,001 for the
%aER 60' and 120' pest infuaion). These results indicate that
exagerated natriures±a was not ocured in 60% of hypertensives of
this study probably because of an inapropriate reduction of PER
which mast be responsible for the esallea REP increase in these
patients.
PROTEIN INTAKE IS MORE IMPOPTANT THAN BE ODD GLUCOSE IN THE
MODULATION OF CER IN DIABETIC GLOMERUL±R MTPERFILTIIATIDN.
P.Kontessis, S.L. Jones, J.R.Pinto, FT.Dodds, E.Bognctti
M.Wisesan snd G.C.Viberti.
Blood glucose and protein intake sodulate gloserular fil—tration rste (GFR) in diabetic humans. We studied the ef-
fect of these two variableain B diabetic patients (pts) with
gluserular hyperfiltrstion (HfGfR 135) and B with norssl
GER (NF:BD—120s1/sin/J.73s'). A meat seal (BOg protein)
was given during hyperglycaesic (H) or euglycaesic () clasp
after 3 weeks of norssl protein (NPD) or low protein diet
(lPD:40g /day). In Hf pts on NPD inulin clearance GfR and
PAM clearance RTf did not increase after seat ingestion
either during H (CFR:152±5 vs 159±5, flPf:722i45 vs 773t73sl
/sin/1.73m'; p;D.2) or I (GfR:14B±5 vs 15Bv9, RPf:695±54 vs
747sSDsl/sin/1.73m'; prD.2. PD lowered basal taR and RPF
and restored the response to a seat seal whether on H (GfR:
l27v4 vs 155±8, llPf: 692v70 vs 7BSv65sl/sin/T.73s'; p 0.05)
or I (GFR:133io vs J4BsB,RPf:654±7B vs 729±79s1/sin/1.73rn';
p 0.05). In Nf GFR and RPf rose in response to protein load
(GfR:llI±7 vs 125±4, RPf:514±25 vs 639±71s!/sin/1.73m; p
0.05) independently of previous diet and prevailing glycae—
sic level. The fEof albusin and IgO rose after the seal in
Hf and NT whether on NPO or IPO independently of prevailing
glycaesic level. Glucagon (190) secretion rose by 30% after
seat seal in all esperisental conditions. Renal response to
protein load is ispaired in Hf on NPD independently of gly—
caesic level and is restored to norsal by LPD suggesting
that protein intake predosinates over glycaesic control in
the acute regulation of these pta. 190 does not appear to
be a mediator of these responses. A protein load consisten-
tly alters gloserular permeability independently of GfR
changes.
Abstracts
TWO CENTER EXPERIENCE WITH 169 TORONTO WESTERN
HOSPITAL (TWH) PERMANENT PERITONEAL DIALYSIS
CATHETERS
N. Dombroe, A. Katirtzoglou, T. Moundokalakis, D. Ikonomo-
poulos, E. Balaskas, N. Apostolidis, A. Tourkaritonis
Peritoneal Dialysis Units of lppokration Hospital, Athens and
AHEPA U/ty Hospital, Thessaloniki, Greece
This study reports the total and particular experience
of two Peritoneal Dialysis Units (PDU-1 and PDU-2) with
86 TWH-1 and 83 TWH-2 catheters respectively, implanted
surgically in 154 (77 and 77) CAPD pts (median age 56, range
19-83 yrs) from November 1982 to July 1989. In PDU-1 the
catheters were implanted with a parameclian incision in 45,
medion in 35 and high Roux in 6, under general anesthesia
in 76 and epidural in 10 cases. In PDU-2 all catheters were
implanted with a paramedian incision under local anesthesia.
By like table analysis the actuarial survival rate for the first
four years was similar in both groups - 89.1, 83.8, 72.7 and
62.7% for TWH-1 and 93.9, 84.2, 75.4 and 63.6% for TWH-2
catheters. The overall complications were 30 hernias, 27 exit
site infections, 14 dialysate leaks, 5 cuff extrusions, 5 tunnel
infections, 5 dislodgements, 3 obstructions and one bowel
perroration. The peritonitis rate was one episode every 16.7
patient months. A total of 30 catheters had to be removed,
12 of which for persisting peritonitis. There were no significant
differences between the two units. We conclude that TWH
catheters have a good survival and that the complications
requiring their removal is relatively low (17.8%).
E'EECTD!ENICS OF THE NON SURGICAL II1PL4NTANATION OF
TENCKOFF CATHETER IN PATIENTS ON CAPD.
Vargemezis V ,Pasaclakis P,Thodis E,Hftimiadou
A,Kaisas G,Avramidis 0.
Division of Nephrology,Democnitous University of Thrace,
Alexandroupolis.
From October 1985 to August 1989,68 straight iou -
ble—cuff Tencboff catheters were inserted by trocar in 61
patients for CAPD (53 pts) or IPO (8pts).The insertion wa
made under local anaesthesia with a midline incision and
the PD program began immesiately after the catheter impla—
tatios ip 55 pts (90,2%).The early complications were dia—
lysate leakage )ll,7%),transient displacement with Outflow
obstruction (1,l%),extruded external cuff 1,6%) and perI-
tonitis (1,4%).The tate 1 15 days) complications were dia—
lysate leakage (2,9%) transient Obstruction (2,9%) displa-
cement of the catheter with obstruction 12,9%) displacement
of the catheter with adequate drainage (8,8%) and exit side
infection (S,9%).In 7 pta (13,2%) catheter was removed 3
in the first 6 months,2 after 12 months and 2 after the
third year.The causes were accidental removal out of the
pelvis (11 pelvic dislodgsent—obstructjon (A),intractable
peritonitis (2).The frequency of adbomlnal hernias was
11.1% (9.2% in the first year).These complications were
comparatably fewer to those observed in many studies with
the usually recommended surgical implantation technique.
The easy performence,the absence of any serious complica-
tion and the estimated effectiveness suggest that this
"trocar insertion method" remains useful -and safe techni-
que for an experienced nephrologsst in the management of
renal failure.
NIFEDIPINE INTRAPERITONEALLY INCREASES ULTRA-
FILTRATION IN CAPO PATIENTS.
E.Balaskas, N.Dombros, N.Savidis, i.Pidonia, A.Lasaridis,
A.Tourkantonis.
1st Dep/nt of Med. AHEPA U/ty Hospital, Thessaloniki, Greece
We studied the effect of Nifedipine (N) on ultrafiltration
in 16 (12 female, 4 male) patients aged 56÷9 (x÷SD) years,
(range33-74) with and stage renal failure undergoing
Confinuous Ambulatory Peritoneal Dialysis (CAPD) for 25.5+18.7(range:3-67) months. None of the patients had recent
peritonitis. Following an overnight exchange, a 4-hour, 2L,
1.5% glucose exchange was performed in each patient on
day 1 (control exchange). On day 2, under the same conditions,
2mg of N were added into the morning bag (study exchange).
Ultrafiltration (&nI), sodium and potassium transfer(mEq), creatinine and urea mass transfer area coefficient(mI/mm) and glucose transfer (mg/kgBW) were calculated
in control and study exchanges. The results showed a highly
significant increase in ultrafiltration (-423.1÷273.1 vs 29.4÷195.2
p0.0001) sodium transfer (6.4+28.4 vs -34.9+20.3, p-0.0001)
and potassium transfer (6.7+1.7 vs 7.8+1.8, p'0.0001) in the
N containing exchanges. There were no differences found
in creatinine (12.5÷3.3 vs 12.8÷4) nor in urea (20+3.2 vs 21÷7.7)
mass transfer area coefficient, nor in glucose transfer
(277.9÷71.6 vs 264.7+68.9). There were no side effects noticed.
Our data indicate that nifedipine, given intraperitorieally
at a dose of lmg/L of dialysate, increases ultrafiltration,
in CAPD patients.
VERAPAMIL INTRAPERITONEALLY INCREASES ULTRA
FILTRATION IN CAPD PATIENTS.
E.Balaskas, N.Dombros, N.Sanidis, I.Pidonia, A,Lasaridis, A.
Tourkantonis.
1st Dep/nt of Med. AHEPA U/ty Hospital, Thessaloniki, Greece
We studied the effect of Verapamil (V) on ultrafiltration
in 16 (12 female, 4 male) patients aged 56.7÷7.6 (x+SD) years,
(range:45-73) with end stage renal failure undergoing
Continuous Ambulatory Peritoneal Dialysis (CAPD) for 20.1÷12.2(range:2-51) months. None of the patients had recent
peritonitis. Following an overnight exchange, a 4-hour, 2L,
1.5% glucose exchange was performed in each patient on
day 1 (control exchange). On day 2, under the same conditions,
10mg of V were added into the morning bag (study exchange).
Ultrafiltration (tnl), sodium and potassium transfer(mEq), creatinine and urea mass transfer area coefficient(mi/win) and glucose transfer (mg!kgBW) were calculated
in control and study exchanges. The results showed a highly
significant increase in ultrafiltration (—335.6+164.2 vs
-84.6÷151.2, p0.0001), sodium transfer (0.1+31.4 vs-21 .6÷29.7,
paO.025) and potassium transfer (5.6+1.1 vs 7.3+1.1 pO.00O1)
in the V containing exchanges, There were no differences
found in creatinine (13.7+6.6 vs 13+6.1) nor in urea (18.3+3.2
vs 20.9+5.7) mass transfer area coefficient, nor in glucose
transfer (294.8÷90.6 vs 295.5÷91.1). There were no side effects
noticed.
Our data indicate that verapamil, given intraperitoneally




EVALUATION OF ONS—FUNCTION IN UREMIC PATIENTS USING
MAGNETOENGEPHALOGRAPHY (MEG).
Thodia E,Pamadakia P,Apostolou E,Eft±miadcu A,
Avramidis D,Martinia G,Vargemezis V.
Dept.of Nephrolngy,Thrace University,Alexandroupolim
GREECE.
In order to evaluate the 055—function in uremic pa—
tienta,we meaaured the aagnetic activity emmited from the
brain of 10 uremic pta on regular hemodiaiyais using tho
RIGMAGNETOMETER SOUID.Gur technique consisted of taking 32
consecutive records,of one second duration each,from the
32 equally spaced points choaen on the uremic scull around
our reference pointmT3,T4,P4;P3,Fk of the international 10—
20 electrode placement point ayatem.Gur MEG data were con-
verted using an AD—converter with sampling frequency 256 Hz
and stored in a PC.Using fourier statistical analysis in
the above data we constructed a map which gives us the din—
mtributinn of the iso—spectral amplitudes of the MEG power
spectrum from each one of the measuring points and for
three particular frequency ianda,2—7 Hz (pathological band),
8—13 Hz )a—rythm),14—2G Hz )b—rythm).Gur results ahoweG ad—
normal high spectral amptitudam)in the band 2—7 Hz) which
were more prominent in pta who were in hemndialynia for mo-
re than 5 yeara.Ne conclude that the use of magnetnengepha—
ingraphy can ie useful in evaiuntinn of C5S—funntinn and
proiaity in the detection of early nugnn of uremic engepta—
lngrapty.
INTRACELLULAR POTASSIUM (K) AND ITS EXCRETION IN PERITONEAL
DIALYSATE IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL
DIALYSIS (CAPD).
A.Katirtzoqloa, Th.Paradellia, N.Anostolidis, Dora—Macones—
los-Svmvoalidis, N.Kallivretakis, Th. Ileantokalakin.
2nd Department of Internal Medicine, Athens University,
Medical School, Hippokration Hosoital and Institete of
Nsclear Physics "Democritos" Athenn - Greece.
Patientn on CAPD only rarely develop clinically nignificant
hynerkalemia and no dietary restrictions are assally impo—
ned to them. Since mont of the body K is located within
cells we ntsdied the effetE of CAPD on intracellalar (ery-
throcyte) K andnerae Kleveln in association with the trans-
port of the ion throagh peritoneal efflaent. Seram,ervthro-
cyte and peritoneal K wan asnensed by I—rae flaorencence in
24 patients sndergoi nq CAPD for 1 to A3 months. According to
the daration of treatment natients were divided into three
greaps: Greap A n=l0, 1-9 a (mean 6m): nrosp B n=8, 13-23 e
(mean 1/n); and groap C n=8, 32—43 m (mean 38e). Fosrteen
chronic aremic patientn were aned an control groap and nor-
mal ealsea were obtained from 52 healthy sabiects.Mean (±53)
seram K wan l64±2A ag1ml in CAPD patients as a whole, 172a28
an/el in aresic patients and 165±21 pg/el in healthy sub-
jects. No significant difference eaisted among groaps A, B
and C. Corresponding valses of erythrocvte K were 3923±1023
pg/al, 3506±680 pg/el and 3051±557 pg/el (n=l7). In CAPD pa-
tients valves tended to increase with the duration of treat-
ment. Mean peritoneal K to seram K ratio was 0.08±0.25 indi-
cating establishment of balance. Mean daily K earetion in
peritoneal effluent did not differ significantly among
groans A, B, Cand in the whole groaps ef natients on CAPD
(1.78±D.Sg) was mach lower than the aeoant of K normally ea—
reted in the anne (2.4±0.25). This finding might be eanlai—
ned as indicative of decreasedintestinal absorption or in-
creased intestinal escretion of K. It is concladed that de-
spite normal serve K valves patients treated with CAPD for
a long period of time are is potential risk to develon in-
creased intracellalar K levels.
PREVALENCE OP HCH ANIIHODIES
1ff FthIR HE1IODIALYDIS UNITS IN AlIENS
I. Lilis, 5. Hadaacoostantinoa, A. Kranaritia, L. Iloamas and C. Loaazai.
blood Transfusion Centre and Nephrology Dept. San. Hospital'A. Fleming' and
Nephrology Depts. NDITS Hospital and 7th Hospital of lEA.
Patients on hospital hemodialysis are prose, among others, to viral nanny—
cowial infections, an it is known for hepatitis 8. An far as hepatitis C, it is
net as yet knoei whether it is transmitted by blood transfanioo, by the same
ways as other viral nossocomial infections or both.
In order ts stady the prevalence of HCV, the recently inolateo caaaative niran
of non A non 8 hepatitis, in hospital hemodialynin populatioe we tested sera
roe 208 ESRU patients treated in Novenher lSfV in 4 renal units in Athens and
from 482 healthy volasteer tlood donors from the same area. Tests were carried
ant by Irthos 'HCV antibody Elina lest Syntee'. Aliponitive for fEY aotibndien
sara were also tented for ALT leveln.
Results: Thirty sin asong 208 patients 117.30.) were found to be positive for
HEY antibodien. Range for the prevalence in each individual anit 3.850—27.71:.
ALT levels above noreal range were eeanared in lb among Ia 27.8±1 HCV positive
pationts. Positive HEY sara core found in S oat of 482 (1.047.1 volunteer blued
donors.
cnnclvnionn: The prevalence of ICY positive patients 17;IlX1 in hemodialysin
snitn in Athens in significantly greater than in volunteer blood donors llv4'hl
raw the name urea n°'AS.54,p<ld71 and higher than the percentage of Hf
pssitiee dialynin patients (5.7/.) treated in greek dialysis units aaring the
lVao—19f7 period. In view of the present limited knowledge on the HEY
iravneinniao, we recneeenn the application of the abave HEX tent tn all dialysis
pata en tn
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STUCT Of ttypolHAtAMos—pITurTARy—GDNADAL AXIS IN DIALYSED
PATIENTS ON RECOMBINANT EBYTHRTPOIETIN (rHuEPO).
K.Platsakis, GRasses, P.Tetsos, N.AfenEakis, P.Zirnyanniw.
Department oE Nephrology, Athens General Hospital
The endocrine profile changes were studied during 20 weeks'
treatment with r—Hu—EPO. The subjects were 8 patients (5s
and 39) aged 25—55 being en chronic replacement of renal
function for 14—108 monthw. The drug waw gieen IT in a
dose of 50 u/Kg per session fcc the first siw weeks, 18—36
u/Kg for the nest six weeks and 20—32 u/Kg for the rest of
the time.
Basic levels of the anterior pituitary gland hormones and
testosterone (T) aere measured by RIA methods before and
during the 6th, 12th and 20th week of therapy.
As it was expected, Mt rose from 19,28±1,07 to 29,82±1,02%
(p<O,001) in 12 weeks.
There were not statistically significant differences in TSH
and OH levels while ACTH showed a trend opposite to the one
of Ht. Changes of PRL, LH, ESH and T In the male patients
are shown on the table.
0 6 12 20 N.R.
PRE (ng/ml) 12,74±3,7 14 9,64±3,51m 9,48s2,85T (11,8—15,9)
EM (mb/mI ) 13,64±2,63 19,8 x4,4D 15,48±4,63 9,86±3,79 ( 1,5—14
ESH (mlu/ml 5,88±1,99 6,32±1,85 9,5 x2,67 7,1 1,0—10,0)I (nmol/t) 14,92±2,67 15,98±2,86 17,54v2,13° 9,92±1,73 (10,5—35
Paired L test 5p< 0,05 5p< 0,01 5pc 1,001
Ihe female subjects exhibited the same trend which was fol-
lowed by regular menstruation in two of them. Am improve-
ment in sexual function was reported by all males.
Conclusion: The correction of anemia with r—HoETD is accom-
panied by recovery (at least partial) of the hypothalamus—
pituitary—gonadal axis, which possibly explains the impro-
vement of sexual function. Reduction of drug dose wan fol-
lowed by a fall in a Mt and a reversion of the horxone
changes supporting the effect of the drug on the avis.
DETIOGRAPHICAL AND MEDICAl. DATA DN CRF
GREEK PATIENTS (DECEMBER 1989)
M. Sarris,Dl.Papadaki,An. Macrynicola, J.Tsiamis
C.Stavropoulos-Giokas, M. Varla-Leftherioti.
- Mellenic Transplant Service (YSE)
Kidney patienti record data are presented
conceroing xex,age, blood group, patienti distri-
bution, the cause of reoal faiiure, the method of
treatment, the time period mince first dialysis,
the percentage of candidate kidney recipients as
well as Other medical information (IIBV infection,
blood transfusions,cytotoxic antibodies.). There
are also presented data on the regional destri-
hutioo of hemodialyzed patients. Analysis of the
above data showed: Most of the kidney patients are
men (60%), between 49-70 yrs old (65%) and belong
mainly to blood group A (52%) and 0 (41%). The
maan cause of renal failure is gloiseralonephritis
most of the parients are in hemodialysis treatment
(85%) ,25% of the patients are coocidered as candi
date recipients,6% are 1185 antigen positive and
45% of those tested for anti-HBs antibody were po-
sitive.45% of the patients have received blood
transfusions and for most of them (56%) the number
of transfusion was 1-5 . 251 of the candidate
recipients are hyperimmunized while 787 of them
had no cytotoxic antibodies. 32% of hemodialyzed
patients have to move to regions out of the place
of thes,' permenent residence. 56% of the total
number are hemodialyzed in hospitals in Athens
area, and 26% of them are travelling for that
from other regions.
Abstracts
CHRONIC EXCESS 00 PAPATHYROID HORMONE (Pm) INCREAS-
ES CYTOSOLIC CALCIUM ICC) OF BRAIN SYNAPTOSOMES AND REDUCES
TREIR ATP CONTENT.
P.Koureta—Eotsiani, M.Smogorzewski,G.Fadda, A.Pernm & C.
Nasary.
Division of Nerhrology, University of Southern California,
School of Medicine, Los Angwlea, CA.
Previous studies have shown that PTN increases brain calci-
um content in brain aynaptoaosiea and this derangement ad-
versely affects their metabolism.However, data documenting
an increase in CC are lacking.
We examined with Fura -2 the level of CC in brain symapto—
somea of 1)18 normal rats, 2) Brats with 3 weeks chronic
renal failure )CRF), 3) 8 parathyreoidectomized )PTX)rats
with CRP, 4) 12 CRF rats treated with verapamil for 3 we-
eks, 5) 8 normal rats injected with 7PM for 3 weeks We
examined, also, with luciferase the ATP content of synapto—
sumea in the previous groups cf rats.
CC in oN was 344+39 for normal rats, 437±- 12 for CRF rats,
363+23,2 for PTX rata with CRF, 361+43 for veraramil treat
ed rats with CRF and 428± 11,6 for normal PTM injected
rats, while ATP content in nM/mg protein was 4,49±0,63,
2,95±0,23, 4,03÷0,61, 4,05±0,67 and 3,06±0,36 in the sa-
me groups.
Our results show that CNP and chronic injection of PIN in
normocalcemic normal rats increase significantly )P<0,Ol)
the CC of brafn synaptososes and reduce their ATP content.
Parathhyroidectasy and verapamil treatment in CRF prevent
these abnormalities.It is possible that these changes in CC
are in part responsible for the derangament of NE metabo-
lism in brain synaptosomes.
RENAL REPLACEMENT THERAPY IN OLDER, TYPE 2 DIABETICS
AN Tzamaluokas, All Narford, PC Zager, PS
Avasthi, U Gibel, AY Smith, MS Sterling, Deparrments of
Nediioe and Transplantation, University of New Mexico
School of Nedicine, Albuqaerque, New Mexico, USA
Type 2 diabetics represent 40% of the patients
entering our end—stage renal disease program at age 55 er
older. In a periud of 18 years, we treated by chronic heme
dialysis (CuD) 58 diabetics, by GAPD 34 and by cadaveric re
cal transplantation (CRT) 10. Age (years) at the beginning
of treatment was as follows: CND 63±5, CAPD 63±5, CRT 61a5.
Cerrespunding deration of treatment waa 21±19, 22±19 and
i8si6 months. Patient survival waa aa follows: 1 year, CBD
71.7%, CAPD 82.6%, CET 90%. 2 year, CND 54.4%, CAPD 56.4%,
CR1 79%. 3 year, CND 42.5%, CAPD 36.9%, CR1 67%. 2 and 3
year survivals were statistically better fur the transptan
ted patients than for those treated by dialytic methods.
Compared to diabetics, older patients with end—stage renal
failure from primary renal diaeaae nave significantly bet
cer survival (2 year survival, CR0 87.7%, CAPD 90%, CR1
90%; 3 year survival CHD 73.9%, GAPO 80.9%, CR1 80%).
Cnrdiuvaxcular disease caaaed 66.8% of the deaths in diabe
tics civ CMO a:±d 61.6% of the deaths in diabetics on CAPO.
te conclusion, type 2 diabetics starting dialysis for end
stage renal failure at en age greater than 55 years have
iecrvawed mortality which is caused primarily by cardio
vascular disease. The better survival of transplanted die





M.Elisaf, A.Drosos, f.Skopouli, K.C.Siamopoulos and
H .M .Moutsopoul Os
Department of Internal Medicine,
University of loannina - Greece
Abstracts
Sjdgren's syndrome is a chronic autoimmune disorder
characterised by a lymphocyte—medi9ted destruction of exo-
crine glands, leading to diminished or absent glandular
secretions and mucosal dryness. In about one fourth of pa-
tients, the lymphoproliferatise process extends to extra—
glandular sites, such as the reticuloendothelial system,
kidneys, muscles and lungs. The most recognised renal hi-
stopathologic lesion is en interstitial nephritis with ma—
ifestations including: Renal tubular acidosis type I(RTA I),
nephrogenic diabetes insipidus and hypokalemia. We des-
cribe 3 cases of primary Sjbgrens syndrome with nephroca-
linosis and diminished renal function. The patients age was
29—42 years and the duration of the syndrome 2—8 years.The
main extraglanduler manifestations were:purpura(2 patients)
arthritis (1 patient), renal colic (1 patient), polyuria
with nocturia (1 patient), muscle weakness (1 patient) .411
three patients had RTA I (hyperchloremic metabolic acido—
sis with a normal anion gap and alkaline urine pH). One
patient had hypercalciuria and 2 had hypokalemia with high
urine potassium. Diminished urinary concentrating capacity
was also found in all patients. The diagnosis of neØirocal-
cinosis was made by percutaneous kidney biopsy in two pa-
tients and radiologically in the third.Interstitial nephri-
us was found in both biopsies. The patients care was sym—
ptomati c.
In conclusion, nephrocelcinosis and the subsquent renal
iopairment may be a manifestation of the tubulointersti—
tial renal damage in patients with primary Sjdgrens syn-
drome.
URdL!THIAIIO: EF!bEillJLuuiiPEiuF CALC'JLI
L. vazeos. 0. FapatheodorOu
aol Army Len. hospital of Athens
Urol itr,iasis Laboratory
this work is about the rreguencY or the
various types or urinary calculi acoordine to
their morphology and stone components ano about
clinical sigr,irioance or the precize knowledge
oi stone composition and localization or eaoh
component. The aoalytioai data are based on the
analysis or 2000 urinary calculi rrom two
groups. Group I igeneral population' and
group II (men.aee ia-iS years'. Calculi
esamination includes macro and microscopical
study and analysis oy means or IR-spectrosoopY
(solid state tecnnfque-Kllr pellet'. For a stone
analysis samples are taken rrom core, iayers
and surface.
Conciderable dirterences in stone compotition
were round in patients or two groups and their
etiology is discussed. The statistical analysis
of analytical data and the morphologic types or
different compotition urinary caiculi are
present as a poster.
The identiricatiOn of stone components. the
difterentiation of various crystallic types for
the same chemical compounds, even those that
aro present in small concentration in the
stone, and their localization at dirrerent
layers or the calculi are very important rot
the understanding or urolithiasis etiology.
The morphology and the structure of calculi
are analogous of their composition and mirror
the etiology of urolithogenesis.
GLYCOLYTIC ENZYME ACTIVITY IN VeINE OF NORMAL PERSONS
C.Tegss,G.Staslasoudakis,G.AeaVn0st0a1isF.Tsimbo5kAis
Clinical Research Laboratory,401 Army General Hospital.Athest
In order to find out sessitine enzyme markers for early detection
of sephrotssicity,the activity of urine glycolytic enzymes was
studied.
Materials and methods:The activity of 14 eozymes(IO of tho glyco-
lytic pathway and 4 of wide usage in clinical practice) was de-
termined is the urise of 30 normal persoes.The assays were per-
formed is early morning urine specimees.6 hours from collectios
at the losgest.A P1 8800 OR/hIS spectrophotometer was ased,and
the eszymic reactions were recorded under constast temperatare
(370 C) for 10 misates.Prelimieary work had bees presiously done.
as necessary for the proper adjustment of the methodology.
the results are demonstrated below (V/t,M SE):
Resskinase(HK) 1.23 0.31
Glucose phosphatn issmerase(GPI) 3.6h 1.32
phosphofructokiease(PEK) 1.90 + 0.79
Aldolase(ALD) 1.96 0.16
Glyceraldehyde phosphate dehydrogesase(GAPD) 4.60 0.41
Mosophosphoglyceromatase(MPGM) 7.73 0.49
Phosphoglycerate kinase(P8K) 25.76 3.54
Esolase(ENOL) 5.04 0.49
Pyrseate kimase(PK) 15.41 1.06
Lactate dehydrogesase(LDH) 27.40 + 2.64
y Glutamyl-trassHePtidasf(YGT) 78.89 3.68
Glutamate—osaloacetate transferase(GOT) 3.66 0.38
Glutamate-pyrasate trassferase(GPT1 3.83 0.49
Creatisise phosphokisase(CPK) 2.76 0.64
Conclusions:1.Glycolytic enzyme actisity is fairly high in normal
urise.2.MPGM,PGK,ENOL,PK and LDH appear to be the most actiee en-
zymes.3.Out of the non—glycolytic eszymes,omly YGT actieity could
be diagnostically useful.4.Oetermisatios of actisity of the fore-
mentioned enzymes in renal tissue aed correlation of data with the
findings of oar study,could lead to the selection of the appropri-
ate enzyme markers for sephrotosicity.
GONTRIOLITION OF URODYFIAMIG STUDIES OF LOWER URINARY TRAGT
GEFORE RENAL TRANSPLANTATION
S. Cortisisdis, Oahr.3. Papailakis. H. haramanis,D. Mavvmdtao
A. Bakirac. P. Lykc'irinas and N.H. Papadodimas.
Dept of Urology and Penal Unit
Tzanion Oen. Hoapitni of Piream — Greece
It is vellknuvn that the integrity nf the upper urinary
tract is depended upon the normal lower urinary trunt fun-
ction. In spite of that,Iittle attention had heen paid hy
the surgeon according to the common urodinamic literature
concerning the function of the urinary bladder before kid-
ney transpianation.
11 peilents with eod star,e renal oisaaae s,pre investigated
by conventional studies hefore kidney tranoplaotation.ln 3
cases there was the suspicion of hladder neck obstruction
on micturat log cystourethrography.Following the above all patients s,hu were on transplanta-
tion list underwent a full urodinamic iovnetigation. The
nhstruction was confirmed in the ahove 3 names. There were
no pathnlogical urodynamic findings in S patients, unstable
hladder was detected in 2 patients and i patients had low
compliance bladder.
So in order to have a full functional picture of the lower
urinary tract, the urodynamic investigation is eassotial
for final decision on perfoming ureterocystoneOstOmy, in
naves of renal transplantation.
EVALUATION OF URINE CULTURES USING EXTERNAL
AND INTERNAL CATHETERS IN ELDERLY MEN.
A.Ef stratopoulos ,P. Tsiodra ,P.Karaqoa—
nis,A.Struza,E.Tsitouras,A.KarakatSani.
District General Hospital of Athens, 3rd.Medical
Dept. and Lab.of Mictobiologv.
Many elderly patients are using frequently
external catheters (UROSAN) for urine incontinenc,
the use of such catheters and the collection
(through them) the urine for culture,is a usual
cause of false positive results and inappropriate
treatment.
- Aim of the present study is -the comparison of
the methods used for urine collection (for urina-
ry culture) in elderly rien:using external cathe-
ters either by the technic of the nursing stuff
(A) ,or with an aseptic technic (B) ,and finally
with internal Foley catheters (C)
— 22 elderly men,aged 70-85 years were studied;in
5 uatients urine cultures were sterile and In
other 3 positive,with all methOds of urine colle--
ction (8/22,33,6%). In the other 14 patients,usin.
the Foley catheters for urine collection all the
cultures were sterlle,while with external cathete
method—A gave false—positive cultures in all 14
patients;with aseptic technic—B 12 out of 14
samples were sterile (91%)
— We conclude that urine collection for culture
through external catheters with the method A has
a high percentage of false —positive results
(63,7%),which is minimized with asectic technic 13
(91% true results) .Thus,to avoid the use of Fole"
catheters in elderly men,we propose the collectior
of urine for culture through external catheters
using an aseptic technic (B)
URIHARY MAGNESIUW ANU CITRATES IN CHILDREN WITH
CALCIUM NEPHROLITHIASIS
A. Al Qadreh, P. Antonopoulou, Ir. Voskaki —Voulgari
Institute of Child Health, "Aghia SophiaChildren's
Hospital, Athens 115.27, Greece.
Urine Magnesium (lig) and Citrates (Cit) have been
considered to contribute significantly to the inhibition
of calcium oxalate crystallization in urine. Were investi-
gated: a) 15 norvial children—controls aged 8.52±2.80 years
(group A) and b) 95 children with idiopathic hypercalciuria
(I.H.C.) aged 9,6±3,6 from which 34 were stone formers
(group B while the other 60 weren't (group C). Calcium
(Ca), Mg and Cit were measured in 24 hour urine collection
in normal diet and the Mg/Ca and Cit/Ca ratios were
calculated. Mg was found statistically significant higher
in the group A and C (p=O,085, p=0,014), while there was
no 5.S. difference in the Cit between the three groups.
The Mg/Ca and Cit/Ca ratios were found S.S. higher in the
group A than in the groups B (p=O,001, p=0,00G) and C
(p=O,022, p=Q,025) while in the group C were found also
higher than in the group B (p=0,042, p=0,031).
Conclusions: In this study was indicated that, the
levels of Mg and Cit in urine or their ratio to Ca were
significantly lower in the stone forniers than in the nor-
maT controls and in the children with I.H.C. without sto-
nes and this is probably caused of calcium oxalate
crystallization in urine.
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EFFECTS OF ANGIOTENSIN CONVERTING ENZyME (ACE) INIII
BTTOPS 05' RE5AL "RA'E CTEA°AN°E ('lUA)
—
If Magoyla,G.Tsapac,K.Paletam-G Ziogas
8' Medical Clinic of Aristotelian University, Thessaloniki
Recent studies have shown a significant decrease in filtra-
tion fraction,indicating efIerenb,ss well as afferent-,
arteriolar vasodilation.Administration of (ACE)inhibitors
has been found to produce sodium loss and this effect may
be related to changes in renal haemodynamics which irdgced
:'ecreamed sodium reabsorption iii the proximal tubuLe.
In the present work,we studied the effects of perindopril
a(ACE) inhibitor,on renal urate clearance after a single
dose of 8mg orafly.The study was performed on ten patients
(7 women,3 men,45—65 years old) hospitalized for investi-
gation and treatment of essential hypertension.
None of the patients had left ventricular hypertrophy,or
renal fsilure.Plasms creatinine levels ranged from 1.00
to 1.23 mg% and serum urste levels ranged from 3.81 to
5.78 mg%.
On day O,at 1000 a.m. ,the patients were given 8mg pen—
ndopril orally;Blood pressure (SB? and DBP)and heart pate
were measured at—2h,Oh and every 2h until the tenth ho' r.Urine was collected every 2h mmcl six consecutive clearance
period were made,one before and five after perindopril
ingestion (preliminary results had indicated that maximal
(ACE) inhibition should occur 4 8h after the drug intake.
Perindopril lowered blood preu.ure significntly.After6h,SBP had dec'easod from 18p.5-. 9.6 to 138.5— 6.72 and
DBP from 109.5— 7.22 to 93.5— 6.72 (p <0.001).The change
in the heart rate was not significant.
The fractional urate excretion (FE.0 ) increaed significa1
ntly 6—8h after acute dru3 intake from 0.10—0.02 to 0.15 -
0.05 (p ,O.OO1).This ua-icosuric effect may be related to
changes In renal haemodynamics which induced decreased
orate reabsorption or increased orate secretion in the pro-
ximal tubule.
THE EFFECT OF NIFEDIPINE (N) ON CIS—PLATINUI (C—PL)
NEPHROTOCICITY
D.Staoatiadis, A.Aqrafiotis, I.Donta, L.Iiakopoulou, D.Per—
rea, P.Karagiannakos and Gr.Vosnides
Division of Flephroloqy and Lab, of Exp. Surgery of the 2nd
Prop. Clinic of Surgery of Univ. of Athens — Laiko General
Hospital - Athens — Greece
To evaluate the potentially protective effect of N on
C—PL nephrotoxicity, a single intraperitoneal injection of
C-PL was given to 30 Wistar rats.. For 2 days prior to and
5 days after the C-PL injection, 20 of the animals were on
intraperitoneal administration of 8 0.3 mg/kg/day (lOrats)
or 0.8 ag/kg/day (10 rats), while the remaining 10 rats
did not receive N (controls). Serum creatinine was deter-
aimed prior to and on the 5th day after C-PL administra-
tion, when removal of the kidneys and semiquantitative as-
sessment of the pathological lesions were performed. We
observed that: 1) Seruri creatinine increased significantly
(p 0.001) in all groups. 2) The percentage increase of
serum creatinine in the group which received N 0.3 mg/kg!
day (ll8±7l) was significantly lower than that of both
the controls (295±84, p = 0.02) and that of the group
which received N 0.8 mg/kg/day (499±265, p (0.001). 3)
The percentage increase of serum creatinine in the group
which received 1! 0.8 oq/kg/day was significantly higher
than that of the controls (499±265 - vs — 295±84, p =
0.01). 4) The pathological lesions were significantly more
severe with N 0.8 eg,'kq/day than those observed in the
controls (p = 0.01) while those with 14 0.3 mg/kg/day were
significantly less severe than those of the controls (p =
0,01). The results of the present study indicate that C—PL
nephrotoxicity may be reduced with low doses and augmented
with high doses of N. This nay prove to be of importance




MECHANICAL CARDIOPULMONARY RESUSCITATION (CPR)
IN PATIENTS ON CHRONIC DIALYSIS
AN Tzamalonkas, CR Murata, PC Zager, C Mur
phy, K Rogers, SJ Quintana, M Nevarea, Department of Medi
doe, University of New Mexico School of Medicine,
Albuquerque, New Mexico, USA
Renal osteodystrophy has a negative impact on
the outcowe of CPR. Only 3 among 26 patients (hemodlalysis
17, CAPD 9) who had CPR survived. Muitipie rib fractures
durInx CPR cuntributed to the death of 10 patients. This
ioforwation was presented to 144 patients (7 women, 137
men, 89 on hemodialysis, 55 on CAPD) aged 23—87 (57113)
years. The patients were then asked to declare whether they
want or do nnt want CPR in case of sudden death. 92 pa
rieots declared that they want CPR (GROUP A, 641) and 52
(361) that they do nut want CPR (CROUP 5). variables which
correlated with refusal of CPR incinded advanced age (GROUP
A 54±13, CROUP B 63±19 years, P<O.O01), the presence of dia
betes (P<O.001), the presence of malignancy (CROUP A 1/92,
UROUP B 8/52. P<0.001), the presence of advanced medical
disability (PcO.OO1) and the presence of advanced 50cm
economic distress (P<0.0O1). The aex of the patients and
the method and duration of dialysis did nut correlate with
the choise of CPR. In cnoclusfun, one third of the patients
un chronic dialysis do nuf want CPR in case of sudden death
The decline of CPR reflects the gravity of the medical con
dition and indirectly the pour quality of life.
NONINVOSIVE MEASUREMENT OF A—V FISTULA RAEMOOVNAMIEG
5.5. Vosdekis MD', F. Helsis MU', Uobr. .1. Papadakis,
H. Lysperopoulos MD, S. Cionnncnpouiou RN°, 3. Verges MD,
N.H. Papadodimss MU.
Renal Unit and Vascular Laboratory (5)
Tzaninn General Hospitol, Piraeus, Greece.
An important fscinr influencing the hoemodialysis success
in patients with end stage renal, failure (RE) is the adeq-
uate flow through an A—V Eistule (AyE). The uoe of strain—
gouge plethyomography (SUP) provides a nnninvasive techni-
que of assessing the various hanmodynasic parameters in the
limb under examination. Tha aim of our study was to use GGP
in the assessment of AVE in patients with RE and in iribnil—
fy the measurements that can he used for the follow—up of
AVE haemndynamics.
Eighteeo patients with RE and a Ciminn AVE (grnup A) sod
11 normal volunteers (Group H) were examined using SCP.The
flow in the forearm proximal in the AVE was eiamiond after
venous occlusion.
The venus parameters measured (mean±SD) end the level of
statistical significant defference (t—test, ':p< G.Ui)
Group A 8
1. Arterial inflow (mT/lDOml/mio) 35±10 li±11
7. Venous capacitance (ml/lOUml) 1.9±1 2.1± 6
3. Maximum venous outflow (ml/lUUmi/mio) B4±17 6B±29
There was oo correlation among the various haemodyoamic
parameters and the duraiioo of AVE or the arterial pressu-
re of the AVE.
We conclude that by measuring the arterial inflow and the
maximum seoous outflow io the forearm it is pnsaible to
assess the function nf the AVE. The SUP should be used for
the 000iovasive evaluation and the follow up of the AVE.
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CARDIOPULMONARY FUNCTION IN IIAEMODIALYSIS
PATIENTS BEFORE AND AFTER TREATMENT OF ANAEMIA
WITH ERYTHROPOIETIN
D. Tsakiris, M. Asramidis, K. Karamitsos, 0. Papadopoulou, A.
Kelesidis, G. Sakellarieu, 0. Memmos, A. Kontopoulos, M.
Papedimitriou
Renal Unit, Aristotelian University, Hippokratean Hospital,
Thesuelsniki
We studied the cardiepulmenary function of 7 hesmedialysis (HO)
patients with severe transfusion - dependent anaemia (Ilt20%)
before tratment with erythropoietin (EPO) and after the therapeutic
goal was acheived (Ht:30-35%). Cardiac fooction assessement
included submaximal tredmill ergometry and measurement of EF,
LVEDD, LVESD, LA diameter, IVS thickness sad LVPW thickness
using a 20-and monodiamension ultrasound machine. Pulmonary
function assessement included FVC, FEVO.75 see, FEy 1.0 eec, PEFR,
FEF and MBC which were carried out with a Vitulograph spirometer.
The interval between the two assessements was 16.3±2.5 weeks
(range 12-21 weeks).
On repeat examination the exercise tent was improved significantly
(7.4±2.1 vs 8.7±1.8 mi pcO.OZ). This improsement was due to an
increase in the EF (0.50±0.03 vs 0.51 pc0.05). There was a
reduction in LVEDD and LVESD (50.1±4.3 vs 49.6±4.3, NS and
24.5±2.) vs 23.9±2.2, NS respectively). The LA diameter, the IVS
thickness and the LVPW thickness remained onchanged. Pulmonary
function improsed significantly as there was a significant increace in
FEV 0.75 sec (2080±670 vs 2150±680 mL, p<0.05), an increase in
FEV 1.0 oec (2290±590 vs 2380±640 mL, p<0.OSI, an increase in
FEF (139±62 vu 145±64 L/min, p<0.01), and an increase in MSC
(83±27vs87±27 Llmin, p<0.0lt
In conclusion, treatment of anaemia with EPO in HO patients
resulted in a significant improvement in cardiopulmonary function.
ACCESS TO BLOOD VESSELS EOR HAEMODIALYSIS - TEN
YEARS EXPERIENCE
A. Casinumis, ICC. Siamopoulos, M. Fatnurox,
M.Pappas, H.Batsis, A.Ciannoukas, G.Sforopoulos
Departments of Surgery and Intornal Medicine,
Medical School, University of Toannina, Oteece
Two hundred and fifty saves access to blood vessels for
haemodialysis were performed on 237 patients with renal fai-
lure in the last ten years as follows One hundred and sev-
enty seven internal arteriovenouu fistulas (A—V fistulas),
14 external arteriovenoax shunts, 2 core-tea grafts and 64
subclavian vein catheters. Twelve shunts functioned succes—
sfuly for 15 (5-30) days until their removal. Two shunts
were removed earlier because of thrombosis and infection
respectively. Sixty two subclavian vein catheters functioned
well for 15 (5—54) days until their removal but two cathet-
ers didn't function because of malpostitioning. One core—tex
graft was used for S months until the patient's death and
the remaining one was thromhosed on the 4th postoperative
day. The A—V fistulas divided with technical criteria as
follows a. Side to side between radial artery and cephalic
vein (143) b. tnd to xide between cephalic vein and radial
artery (10) c. tnd to end between radial artery and cephalic
vein (4) d. A-V fistulas between brachial artery and cepha-
lic or banilic vein (20). The proportion of the A—V fintulan
which functioned after the operation directly, 3 months and
12 months postoperatively as well as the proportion of their
Function 1%) 'atis'!actory
A — V Eistula direct 3mths l2mths function
Group a 88 85 79 93
Group b 90 79 66 78
Group c 180 75 75 50
g gg
Diabetic Nephropethy, arteriosclerosis and Polycystic ki-
dney disease were the most common causes of the construction
failure and malfunction of a number of A-V communications.
ASSESSMENT OF BONE ALTERATIONS IN RENAL TRANSPLANTATION
BY NON-INVASIVE METHODS
A. Karantanas, J. Kalef-Ezra, J. Hatziconstantinou,
G. Sferopoulos, K. C. Siamopoulos
Departments of Medical Physics, Radiology and Internal
Medicine, Division of Nephrology, Medical School,
University of loannina, loannina 451 10, Greece
The influence of renal transplantation on bone status has
not been studied adequately. Twenty renal graft recipients
(RGR) were examined by the following non—invasive in vivo
methods: partial body neutron activation analysis (NAA),
quantitative computed tomography (QCT), single photon ab—
sorptiometry (SPA) and radiogrammetry(RGY). NAA was applied
for measuring the hand bone phosphorus by detecting the de-
layed y—rays emitted from 28A1 produced via the 3'P (n,a)28
Al fast neutron reaction. QCT was applied for assessing the
trabecular bone density of the vertebral bodies T12—L3. SPA
was applied at the distal third of the right forearm (main-
ly cortical bone). The RGY was applied on the right second
metacarpal bone for assessing the cortical thickness.
The results were expressed as percentage of age and sex
matched controls.
(Table)
technique n mean value % range CV.
QCT 17 51% 33% — 75% 24%
NAA 18 87% 66% — 117% 25%
SPA 15 91% 56% — 132% 24%
ROY 12 83% 72% - 102% 13%
Repeated QCT measurements showed a) significant reduction
in density shortly (4 months) after transplantation and b)
increase in subjects with graft rejection who were subse-
quently haemodialyzed. Repeated NAA measurements showed
stability within a two year period.
In conclusion, although no clinical symptoms of osteope—
cia were apparent in RGR, the above applied tchniques show-
ed alterations of bone mineral metabolism of varying degree.
PARATHYROID GRAFT FUNCTION AFTER TOTAL PARATHYROIDECTO1Y
(PTx) IA PATIENTS 03 CHROAIC DIALYSIS
D.Fiemnos, A.3elechri,G.Visvardis,D.Gakis,.Karamouzis,
A.Vyzantiadi x , G.Sakel lariou ,A.Antoniadis ,.Papadimitriou
Dejt.of lephroiogy and Transplant Unit,Hippokration Gen.
Fiosoital, University of Thessaloniki
Forty—one patients (33 haemodialysis, S C.A.P.D.) with
severe secondary hyperparathyroidism (HPTH) had a total
parathyroidectomy. In 22 patients autotransplantation of
parathyroid tissue was performed into the forearn muscles
(1933-1987). Of 19 patients who completed a follow-up pe-
riod >12 months (14-94), 7 developed recurrent HPTH. Five
patients had partial graft removal (Two resections in one
patient). Three of them, despite initial improvement, re-
developed HPTH. This method of implantation was abandoned
because of the high incidence of recurrence and the uncon-
trolled spread of parathyroid tissue requiring resection
of muscle tissue.
Since Septenher 1987, autotransplantation of parathyroid
tissue was performed into the adominal fat tissue in 1$
patients iho had a total PTX. The ten patients who completed
a folio-up period of 12 months (12-23) ad evidence of su-
cessful PTX (initial fall of plasma calcium and iPTH, gradu-
al clinical improvement, healing of radiographic erosions
and fall of alkaline phosphatase). At the end of the folloo—
up period the plasma iPTH is within normal limits in 3 pa-
tients and slightly raised in 2. Five patients receive snail
doses of 1,23 (OH(20
It is concluded that parathyroid grafts can survive and
function in fat tissue. In cases of recurrent HPTH, broad
excisions can be performed, if necessary, without sacrifi-
cing vital tissue. Long tern folIo-up is necessary for a
better evaluation of this method.
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ALTERATIONS OF APPENDICULAR BONE METABOLISM
IN HAEMODIALYZED PATIENTS
J. Kalef-Ezra, A. Karantanas, J. Hatziconstantinou,
G. Sferopoulos, K. C. Siamopoulos
Departments of Medical Physics, Radiology and Internal
Medicine, Division of Nephrology, Medical School,
University of Ioannina, Ioannina Greece
Renal osteodystrophy is a common complication of chronic
haemodialysis. Hand bones are sites of early manifestations
of metabolic alterations. The following non—invasive in
vivo methods were applied in 64 haemodialyzed patients(HD):
partial body neutron activation analysis (NAA), single pho-
ton absorptiometry (SPA) and radiggrammetry (RGY). SPA was
applied for estimation of tne photon attenuation at the
distal third of the right forearm. NAA was applied for mea-
suring the hand bone phosphorus by detecting the delayed y—
rays emitted from 28A1 produced via the 3lP(n,a) 28Al fast
neutron reaction. RGY was applied on the right second meta-
carpal bone for assessing the cortical thickness.
The results were expressed as percentage of age and sex
matched controls.
Table.
technique n mean value C.V.
NAA 5 87% 53% - 111% 15%
SPA 35 87% 60%— 115% 20%
RGY 33 77% 53% — 111% 19%
The application of NAA-and SPA showed a reduction of bone
minerals with time under haemodialysis. Linear regression
analysis showed a corellation between a) RGY and NAA.(r0..58,.
p < 0.01) and b) NAA.arid SPA (r0.44, p K 0.01). Repeated
measurements with NAA in 28 HO patients showed a mean an-
nual reduction greater than that of the controls.
in conclusion, the above mentioned techniques allow the
precise follow - up of renal osteodystrophy.
CORRELATION OF BIOCHEMICAL AND RADIOGRAPHIC PARAMETERS WITH
BONE BIOPSY FINDINGS IN THE DIAGNOSIS OF RENAL OSTEODYSTRFPFIY
D.Memmos, A.Beiechri, M.Karamouzis, V.Vargemezis, S.Hatzianto-
niou, A.Dimitriadou, M.Papadimitriou
Dept. of Nephrology, University of Thessaloniki, Hippokratial
General Hospital and Dapt.of Biochemistry, University of
Thes salon iki
The significance of biochemical and radiographic parame-
ters in the diagnosis of renal osteodystrophy (ROD) was evalua-
ted in 24 CAPD patients who had a bone biopsy. Biochemical
plasma estimations were:Ca,P, alkaline phosphatase,osteocal—
cm (DC), parathyroid hormone (IPTIF:intact,1—84 and MPTH:mid
region,44-68), 25DH vit. D, aluminium (PA1).Hand radiraphs
(mamography) were graded (stage 0—4 of erosions). The quanti-
tative study of non—decaicified ileal bone sections showed
that 10 patients had osteitis fibrosa (OF,group A), 5 had pre-
dominant aluminium osteomalacia (Al-OM, group B), and 9pa-
tients had mild lesions. Group A patients had lower PAl (A:
45.9+30.8,B:222÷117, p<O.0001) highor IPT1I (A:761+550, B:212±
+227p=O.O5) aSd DC (A:44.2+13.4,B:19.2+6.4, p=O.0O2) than
roup B.There was significant correlation between the num-
ber osteoclasts/mm and MPTH (r=0.65,pcO.OOl),IPTH (r=O.55,
p<O.Ol), DC (rrO.54,p<O.01) and stage of erosions (r=D.45,
p<D.05). The extent of trabecular Al deposition had a signi-
ficant correlation with PAl (r=O.76, p<0.O1).There was a (ne-
gative) correlation between PAl and calcified ,bone volume
(rO.58, p<O.Ol) and a (positive) correlation with osteoid
surface (rO.58, p<O.Ol).The was also a correlation between
the stage of erosions and IPTH (rO.81, p<0.OOl), MPTH (r
0.53, p<O.O1) and DC (r=O.44, p<O.O5). Despite these signi-
ficant correlations the biochemical and radiographic parame-
ters were not diagnostic for each biopsy. It is concludad
that IPTH, MPTH, DC and stage of erosions are useful indices
of OF. High PAl levels point to Al accumulation in bones.
But, for the ultimate diagnosis cf ROD, especially in early
OF and Al—OM, a bone biopsy is neccessary.
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HAEIIODIALVSIS (Ho) ASSOCIATED DESTRUCTIVE OSTEOARTHROPATHY
(DOA): RELATION TO SEVERE HYPERPARATHYROIDISM?
Ch.Stathakis, S.Hichael, D.Stamatiadis, J.Boletis, A.Lagou-
ranis, A.Papadoyiannakis, K.Katopodis, A.Katsarou, J.Tsou—
ras, P.Sfikakis and Gr.Vosnides
Division of Nephrology, Laiko General Hospital and 1st
Dept. of Prop. Hedicine, Athens Pledical School, Athens —
Greece
The causes of DOA in HO pts remain uncertain. In order
to evaluate the relation of HO associated DOA to uremic
hyperparathyroidism 40 pts (24 H, 16 F),aged 46.8±14.4 yrs,
undergoing HO with cuprophan dialysers for 1 to 16 yrs (6.1
were studied. The diagnosis of DOA was made clini-
cally and confirmed radiologically. For the evaluation of
hyperparathyroidisn radiological criteria and serum calcium
(Ca), phosphate (P), total alkaline phosphatase (ALP), to-
tal acid phosphatase (ACP) and iPTH (—C and —N terminals),
were used. Also, serum b2 Microglobulin (b2H) and ferritin
were determined as indirect indices of joint deposition of
amyloid and iroe respectively. Although biochemical eviden-
ce of hyperparathyroidism was present in all 40 pts, clini-
cal and radiographic findings of OOA were observed in 6 pts
(15%) only (2 M, 4 F), aged 51±5 yrs. These pts had single
(lpt) or multiple (Spts) joint involvement and were on HO
significantly longer than pts without OOA (pCO.0O1). A
highly significant increase in Ca (p (0.05), ALP (pcO.OOl)
ACP (p <0.001) and iPTH-C and iPTH—N (p<O.OO1) was observed
in pts with DOA, compared to those without DOA. No signifi-
cant differences in age, serum b21f and ferritin levels we-
re found. The results of the present study indicate that
in pts undergoing HO, the development of DOA: 1) Is related
to the presence of severe forms of hyperparathyroidism and
prolonged HD time. 2) Is not related to serum b2M and fer—
ritin levels.
GIGIGL 1WATII€NT IF 1BX)4YRY l-1tFSPAR4I1-6RJIDI Sf1.
A.Kost4ds, G.Zavos, St.Kyrhecidis, nJrbis, K.Oiles, G.Sntirchos,
5t.oirrnal is, GA€cnis, E.Konicdianos, D.Staiutiadis.
Trlantation Center, General Laikon 'r-Ley,i tal, Athens, Greece.
Wriru the tise period Mirdn 83- 0cc 89, 78pts (49i1-3F,Pvn aje:46)
aifferirq from seccrrRry hperpsrathyroidi in' (FF1(sere stri t tad to ía-
ratf'roidectrny (P1%). At the tee of rperat ion 76 of the derive pts sore
on ragjlarl-E) treetrient the to ad stage real failure art 21-nd sncceful-
ly received a kidney graft. Total FIX (4 glads)ees perfoinnad in lQnts,
total FIX fol hued by parathyroid tissne ajrotrannlantat ion in 25 ad
sintotal FIX 10 t4pts. lhree glads acre identified io t4pts, 2 glands
10 lpts, etni lean adenora sos renoved in 3nts tagether al than ljnerpla—
stic glad in 2 of those 3. If all 7nts 2 died dnriag the inealiate
pnstcperative period ad 3 others after 8,12 ad 3beonths remnectively.
lhese pts dna lad total FIX are syiptoni free al tho.n they 1-eve to renmio
en regnlar ainstitution treetnant chile 3of the 2ntsvlnoheda total
P1X ad antotranRnlantation redevelrped I-fiR after 7,18 ad 3) nnnnths res-
pectively, tpt is oiler regnlar abstitution treetrrent ad Ice tpt there
are no coda reed Idel e. lOne rest of the FIXed pts are symptom free. Of the
lipts edo had a sintotal FIX 11 have been cured ad fir the rest 3 there
no coda real Idnle. Of the l1pts in nI-rich 3 glads sore identified byts
are eel I, 7 redevelcped 1-Efisymptons ad for 3 of thorn there are no folIos
n.p cleta. In these pts in vI-onn 2glads care ford ad rennnved no inprove—
sent sos ctnserved.llne plc 10 vtnonn the adenona ems renamed are symptom
free. In conclusion: ldentifyirg all 4 gerett-yreid glands remains the em—
jcr issne of sirgical tremtrrent of I-PR inview of the fact that to cur
eçeriance cmpjterizai toncgrq±y is of no help ad ultrnsoncgag*ny is
of I lid ted value.Total renoval of all 4 grads hes rid inetely solved
the prcblenr inmnite of difficulties in mnaintainirg ncrnml blccd cml ciuni
levels in sore of these pts.
Abstracts
TOTAL SERUN ACID PHOSPHATASE (s.ACP) IN HE1IODIALYSIS PATI-
ENTS PRIOR TO AND IHMEDIATELY AFTER PARATHYROIDECTOMY
Cn;Stathakis, J.Boletis, S.Hichael, D.Stamatiadis, K.Kato—
podis, G.Bristogiannis, D.Goumenos, G.Zavos, S.Kiriakides,
A.Kostakis and Gr.Vosnides
Division of Iiephrology and Renal Transplantation
Laiko General Hospital — Athens — Greece
flAltisough in HO patients s.ACP is the only biochemical
index of osteoclastic activity, its alterations during the
ininediate post—parathyroidectosy period has not been exten-
sively studied in these pts. To evaluate the post—parathy—
roidectomy alterations of s.ACP, this enzyme, as well as,
serum calcium (Ca), phosphata (P), total alkal.phosphatase
(ALP) and iPTH (—C and —N terminals) were determined prior
to and 1,2,7 and 3D days after parathyroidectomy, in 21 pts
(14 H, 7 F), aged 45±10.1 yrs, who were on HO for 6.5±2.7
yrs. Prior to parathyroidectomy, a significant positive
correlation was noted between s.ACP and ALP (p<0.0O1),
iPTH—C (p-(O.D5) and iPTH—N (p <0.001). After parathyroid—
ektomy: 1) On day 1, an abrupt and significant fall in
s.ACP (p= 0.004), iPTH—C (p=O.OO2) and iPTH—N (p=0) occur-
red. 2) s.ACP approached normal values on day 7, whereas
iPTH—C and iPTH—FI continuedto fall gradually up to day 30.
3) ALP did not change significantly. The above observations
indicate that in pts undergoing HO: 1) Immediately after
parathyroidectomy rapid cessation of osteoclastic activity
occurs, whereas osteoblastic activity is preserved. 2)
s.ACP is a reliable index for the assessment of 2ndary hy—
perparathyroidism, and parathyroidectomy.
CALCIUM CARBONATE AS A PHOSPHATE BINDER tN PATIENTS ON
RENAL REPLACEMENT THERAPHY
M.Siakotos, N.Tsianas, J.Malegos, G.Metaxatos, M.Zavros,
P.Mangana, G.Stavianoudakis, D.Georgakopoutou, Al.Gerakis,A.Biltis
Division of Nephrotogy, Evangetismos Hospital, Athens,
Greece
In order to evaluate the efficacy and side—effects ofCaCO3 as a phosphate binder,the drug was given to 58
patients (pts),24 to 75 years old,who were on hemodialysis
(33 pts) or CAPO (25 pts) for 6 to 175 (mean 48,8) months.
Before starting CaCO3 treatment,all pts were receiving
uminium—containing phosphate binders in a mean dose of2,5+0,8 g/day.The daily dose of CaCO3 ranged from 2,9 to
7,2 g (mean .3,6 g) and ths duration of treatment from 6 to
14 (mean 9,2) months .During this period,there was no
change in the diet of the pts or the concentration ofthe dialysate in Ca++ , which was 7,0 mg% for both
hemodialysis and CAPO. After a six month treatment period,
the mean value of serum phosphate (P) had decreased from
5,8± O,9 mgi. to 4,9 0,7 mgi. (p<0,00l),while that of serumCa had increased from 8,8 + 0,6 mgX to 9,2 0,75 mg%
(p<0,Ol). At the end of the study period, the mean serum P
was 4,75t0,75aig% and in 49 pts (84,5%) it was <5,Smg%. A
significant decrease in the mean value of parathormone from659pg/ml to 485 pg/ml (p<O,OS) was also observed. In 5 pts
who showed an increase of serum Ca++ to 10,9—12,1 mg%
CaCO3 treatment was withdrawn. Another 8 pts developed
mild gastro—intestinal complaints , but discontinuation of
treatment was required in only 2 of thee.
It is concluded that CaCO3 was effective in controlling
serum P level in 85% of our pts, but in 12% of all pts
treatment was withdrawn because of side—effects, mainly
hypercalcemia.
INCIDENCE OF HISTOLOGIC FORMS OF RENAL OSTEODYSTROPHY
(NO) IN PATIENTS ON RENAL REPLACEMENT THERAPY
Abstracts
N.Tsianas, M.Siakotos, J.Malegas, N.Nikolopoulou,
B.Marqellos, P.Mangana. D.Xadjigiannakos, M.Tziamalis,
Th.Apostolou, A.Biltis
Division of Nephrology, Evangelismos Hospital, Athens,
Greece
The incidence of the various histological forms of RO was
investigated in 26 patients (ptst (13 M,13 F), aged 20—67
(mean 50,8) years,who were on hemodialysis (20 pts) or
CAPD (6 pts> for 12—153 (mean 62,7±40,9) months. In all
pts ,who were taking aluminium hydroxide as a phosphate
binder, several biochemical and hormonal parameters were
measured (including alkaline phosphate,i—PTH, osteocalcin
and 25lOHtD3t skeletal a—rays and bone biopsies were also
done in all pts. Bone was studied in nondecalcified
sections. Symptomatic bone disease was present in 21
(80,7%) pts. The values of alkaline phosphate, i—PIN and
osteocaicin were highly increased, while those of 25iOHIDS
were decreased in all pts. In 23 pts (88,4'/.t, including
all those with symptomatic bane disease, radiological
findings of R.O.were present. Histologically, R.O. was
found in all pts, except one who had a normal bone
appearence, and were classified as; a(pure asteitis
fibrosa in 10 pts (38,4%), bt osteomalacia in 1 pt (3,8%).
c( adynamic bone disease in 2 pts (7,7%) and dl mixed bone
disease tosteitis fibrosa and osteomalacia) 12 pts (467.1.
In addition, 12 pts (46%) had developed alLiminium—related
bone disease. It is concluded that the incidence of
osteitis fibrosa and aluminium—related bone disease was
high in our pts, but the incidence of osteomalacia was low
compared to the literature.
BONE MASS (EM) IN PATIENTS ON CONTINUOUS AMBULATORY PERI-
TONEAL DIALYSIS (CAPO): EFFECT OF SEX AND DURATION OF
TREATMENT
T.Mountokalakis, A. Katirtzoglou, E. Georgiou, G. Douskas,
H. Prassa, C. Potamitis, C. Proukakis
Second Medical Department and Medical Physics Laboratory,
Athens University
BM is decreased in chronic renal failure as a result of re-
nal osteodystrophy (ROD). In view of the controversy on the
effect of CAPD on ROD, BM was measured, using the method
of single photon absorptiometry (source 125I) at the proxi-
mal (P) and the distal (0) part of the furthest third of
left forearm in 51 patients (30 men, aged 23—82 years and
21 women, aged 23-78 years) who have been treated with CAPD
for 1 to 81 months. The results were compared with the cor-
responding for the age and sex normal mean values (Bn±SDn)
obtained from a group of 261 (120 men and 167 women) heal-
thy subjects. Measurements at P revealed values lower than
2 SDn in 4/21 women and 13/30 men. Measurements at 0 show-
ed values lower than 2 SO in 15/21 women and 11/30 men.
Mean (aSO) standardized difference (z-score) of measured
(x) from expected values, as calculated from the equation
z-score = (x-Sn)/SOn, was -1.49±2.22 in men and —0.81±1.64
in women for P (non significant sex differences); and
-1.27±1.91 in men and —2.52±2.09 in women for 0 (pa0.05
between sexes). A significant (p<O.Ol) positive linear cor-
relation existed between z—score in both sexes and the du-
ration of CAPO. It is concluded that BM is decreased in
patients treated with CAPO, particularly in women and that
BM loss increases with the duration of treatment.
CALCIUM KINETIC STUDIES (N HEMODIALYSIS PATIENTS BEFORE
AND AFTER PARATHYREOIDECTOMY
P. Kurz.T. Tsobanelis,*U. Ewald.*P. Roth, *E. Werner, P. Grijtzmacher,
.Vlachojannis(I. Med.Klinik Akad.Lehrkrankenhaus St.Markus Univ. Frankfurt, FRG
*Gesellschaft für Strahien und Umwe)tforschung Frankfurt. ERG
**Nephrotogy Center University Patras. Greece
Development and progression of secondary hyperparathyroidism(sHPTI
is a common complication of chronic renal failure.The disturbance of
calcium metabolism does not only lead to renal osteopathy but also
favours soft tissue calcifications. Tracer kinetic studys using a whole
body counter help to analyse the influence of parathyreoidectomy)PTX) on disturbed calcium metabolism.
We examined 6 hemodialysis patients wi)h severe sHPT before and
after PTX.They had been on dialysis (or a mean of 5.5 years. Time
between PTX and restudy was 8 months. In all patients aluminium
intoxication was excluded using deferoxamine test and bone biopsy.
After PTX all patients received vitamin 0 supplementation.Calcium ki-
netic studies were performed using two calcium-isotopes l45Ca per
os. 4/Ca intravenouslyland a 4-compartment model. Calcium retention
ICa—Ret) after 28 days. a parameter for bone calcium turnover, and
calcium clearance ICa—Cil. a parame(er for the rapid mixing of cal—
cium with the total exchangeable calcium pooi were determined. This
pool contains the soft (issue compartment. Kinetic parameters were
correlated with biochemical data: serum calciumlCal. alkaline pito—
sphataselAPl,intact parafhyroid hormoneliPTHl. 1,25—dihydroxy—vitamin
0(t,25DHCL
PTX iPTHlprnol/llCa(mval/DAluxg/l)1,25DHClpg/mDCa -Retl%)Ca—Cl
normal 1.2-6.0 4.1-5.2 <40.0 35,090.0 43.0±6.0 2.6±0.2
before 993 5.14 44.0 30.5 58.6 4.12
after 9.0 4.14 32.0 36.8 46.3 3.84
No change was observed for l,25DHC concentration Aluminium levels
did not differ before and after PIX. As expected by the significant
decrease of P FH in serum calcium retention substantially fell and
was in the normal range after PTX. However, only an insignificant fall
was observed for calcium clearance despite the marked change of
iPTH.
These data indicate that (<TX normalized bone calcium turnover as
has been measured by calcium retention. they further indicate that
calcium clearance does Cot solely depend on iPTH concentration. This
finding may axplain the observation in dialysis patients that extraos-
seous calcifications do not correlate with serum IPTH.
CORRELATION OF HISTOLOGICAL WITS OThERS INDICES OF RENAL
OSTEODYSTROPHY (R. 0.) IN PATIENTS WITS MILD TO MODERATE
RENAL FAILURE (CRF)
J.MalegO8, M.Siakotos. N.Teianas. N.Nikolopoulou.
G .Metaxatoe. A.Drouzaa. A.Psarrou. A.Poutopoulos.
M.Zavros. D.Hadjiyiannakos, A.Billis
Division of Nephrology, Evangelismos Hospital. Athens.
Greece
The diagnostic value of --radiological, biochemical.
hormonal and histological indices of R.O. was evaluated in
19 patients (pta) (1314. 6?). aged 32—66 years. with CR?
(serum creatinine (scr) 2—6 mg%. creatinine clearance
(cr.cl.) 15—50,sl/1). Ten pta had s.cr. 2—/dl and cr.cl
30—50m1/min (Group I) and 9 had 5cr. 3—6mg/di and crc!
15—29 ml/min, respectively (Group II). The groups were
matched for sex, age and primary renal disease, but
the duration of CR? was significantly longer in group II
compared to group I (36.5+17.9 versus 59.5+29.6 months
respectively, (p<O.05). In all pts. who were not receiving
phosphate binders, biochemical and hormonal
perameters,including serum i—PTh. osteocalcin and
25(OH)D3). were measured; skeletal x—rays and bone
biopsies were also carried out. All pta were asymptomatic
and had normal skeletal x—rays; biochemistry was also
normal.but serum parathormone and osteocalcin values were
elevated, mainly in pts of group II. Histologically, in
group I nine Pt, had mild (7 pta) or moderate (2 pts)
oateitis fibrosa (O.F.) and one Pt had normal bones
appearance. In group II, 5 pta had findings of mild 0.?.
and 4 had a mixed form of 0.?. and osteomalacia. In this
group, total surface of osteoid and mineralization front
had higher values compared to group I (p(O.O1 and 0.05.
respectively). There was almo a positive correlation
between the total surface osteoid and serum osteocalcin in
group It. These observations confirm that pta with mild
and moderate CR?: a) Have neither clinical or radiological
findings of R.O.. nor any biochemical disturbances. b)
have increased values of serum parathormone and
osteocalcin and histological findings of osteitis fibrosa,
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RENAL OSTEODYSTROPHY IN PATIENTS RECEIVING C.A.P.D. FOR OVER
3 YEARS
A.3elechri, D.Nemmos, E.Petropoulou, P.Koukoudis, G.Grollios,
S.Kyriazides, A.Vyzantiadis, ii.Papadimitriou
Dept. of Jephrology, University of Thessaloniki and Dept. of
Radiology, Hippokration General Hospital, Thessaloniki
Fifty-two patients who completed 3 years on CAPD were stu-
died. (•iean age 54.5 years, iTi-SD duration of CAPE) 49.9+10.7
months). The most frequent manifestations of renal osteody—
strophy (ROD) were: pruritus (18 patients),bone pain (15), my—
opathy (16) fractures (3). Seven patients lad advanced and
17 early terminal phalangeal erosions. Plasma PTH (i4-i-SD) (mid-
region, 44—68) was 3.l+3.lng/ml (normal <O.27)and aliininiun
(RA1) was 60.9+ 728g/L (range 7-372).
Quantitative study of non-decalcified ileal bone biopsies.
was done in 25 patients. Typical features of osteitis fibrosa
(OF) with positive tetracycline double labelling were found
in 10 biopsies (group A). In 6 biopsies (group B) there sre
findings of aluminium osteomalacia (Al—O'i) (2 aplastic):i'lil-
der lesions were seen in 9 biopsies (group C); mild OF in 4
and reduced rnineralisation with mild/moderate Al deposition
in 4 biopsies. There was mild Al deposition in some group A
biopsies while some osteoclasts were found in 2 group 3 biop-
sies. Of the 10 group A patients, 2 had a parathyroidectoiny
and 8 received 1,25 (OH) 0 . Five group B patients received
desferrioxamine (3 intraeitoneal ly).
In conclusion, OF is the most frequent form of ROD in
CAPE) patients. Al-O14 is not rare, while both lesions may
coexist. As the examination of peritoneal dialysis fluid has
shown very low Al levels, the finding of Al accumulation
(occasionally asymptomatic) has led to the reduction of the
dose of aluminium hydroxide and the administration of calcit.m
carbonate.
THE EFFECTS OF CHLOROTHIAZIDE ON BONES AND PARATHYROID
FUNCTION IN CHILDREN WITH IDIOPATHIC HYPERCALCIURIA
Ir.Voskaki-Voulgari, Ch.Megreli, A.Al Qadreh
Institute of Child Health, "Aghia Sophia" Children's
Hospital, Athens 11527 Greece
In a previous work in children with idiopathic renal
hypercalciuria (I.R.H) without therapy the Bone Mineral
Content (BMC2/BW) was estimated lower than in normal child-
ren and were found biochemical indicators of secondary
hyperparathyroidism. The aim of this Study was •to evaluated
the effects of chlorothiazides therapy on BMC2/BW and on
parathyroid function in children with I.)l.H. In 20 child-
ren aged 4.5-13 years with I.R.H. were measured after 12
hours fasting a)in serum: creatinine (Cr), parathormone
(iPTU) and cAMP and b)in 3 hours urine collection Cr (UCr),
calcium (UCa) and cAMP. Were calculated the UCa/UCr ratio
and the nephrogenous cAMP (ncAMP). In two 24 hours urine
collections Ca was measured. BMC2/BW was measured by single
photon absorption. These examinations were considered
before and after 1 and 2 years therpay (hydrochlorothia-
zides O,75—lmg/kg/24h). Statistically significant (s.s.)
lower were found after 1 and 2 years correlated with than
before therapy the parametres UCa/UCr (p<O.OOl, p<O.001),
24 hours UCa (p<O.OOl, p<O.OO1), iPTH (p0.O10, p=O.034)
and ncAMP (pO.0O2, pO.OOl) while BMC2/BW was found s.s.
higher (p=O.043, p=0.0O3).
Conclusions: In children with i.R.H. BMC2/BW, iPTH
and ncAMP were restored with chlorothiazides therapy and
these parametres can be also used as indicators of trat-
ment of hypercalciuria.
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BONE DENSITY IN CHILDREN WITH END STAGE RENAL DISEASE
(ES RU)
C. Stefanidis, I. Voskaki, A. Al Qadreh, K. Kipourou,
C, Mengrelj, K. Michelis.
Institute of Child Health, Aghia Sophia"Children's
Hospital and Renal Division 'P & A Kyriakou" Children's
Hospital, Athens 11527, Greece.
Renal osteodystrophy (ROD) is a significant problem of
children with ESRDbecause is related with growth failure
and bone deformities. Bone density (BD) is considered a
reliable parameter of bone mineral status and of ROD in
adults. Thirty nine a'ssessments of BO were performed in 12
children on hemodialysis (HO) and 11 on continuous ambula-
tory peritoneal dialysis (CARD). The male/female ratio and
the age distribution of patients from the above groups were
similar BD was measured with a single photon method and'was
expressed with standard deviat4on scores (SOS). All pa-
tients were on dialysis for more than a year and were
treated with la—OH f3, CaCO3 and 6/23 with Al(OH)3.A signi
ficant decrease of BD (>
—25DS) was noticed in 7/12
children on lID (—3.4±1.9) and in 1/11 on CAPD (-0.9±1.6,
p<O.02).83% of children on CAPO and 20% of HO patients
had a normal ASDS of BD (>—0.5/year). 72% and 25% of pa-
tients of the above groups had a normal growth of height.
There was a positive correlation of 11 SDS of height and of
BE) (R=0.6 p 0.05). SD was signifimantly decreased in pa-
tients with dialysis for> 2 years (p(O.OO1) and with
increased serum PTH (< 0.01). In contrast there was no
correlation of BD with the radiological findings and with
serum Ca and P. In conclusion:Bone density is a simple and
sensitive index of ROD. 36% of children had a decreased
SD, despite the aggressive management. BD was more frequen-
tly decreased in children on hemodialysis.
BONE DENSITY AND GROWTH IN CHILDREN AFTER RENAL
TWANSPLANTANTION
A. F4itsioni, A.Al Quadra, C Stefanidis, 0. Siapera,
I. Voskaki, K. Michelis
Renal Division 'P & A KyriakouChildren's Hospital
Inst4tute of Child Health, Aghia SophiaChildren's
Hospital, Athens 11527, Greece.
An improvement of renal osteodystrophy has been reported
after renal transplantation (tx). However bone abnormali
ties persist in some children. To assess bone mineral sta-
tus after tx bone density (B.D.) was measured 25 times in
18 children 2.5-16.2 years old. 13/1 children haø.e life
related donor and 5/18 had a cadaveric tx . 5/13 cni drerl
were on prednisolone and azathoprino and 13/18 on cyclo-
sporine additionally The follgw gp period ws U 2
years BQ was measureà with a single pnoton ausorb 1 6 de-
vice aflcJ was expressed as standart deviation score (SOS).
Growth was assessed with the change of SOS/year. In 28%
of children a significant decrease of SO (7-2 SOS) and of
Iiei ght (>—O .5 8 SOS/year) was noticed, There was a si gni-gicant positive correlation of SD and 8SDS of height
tR=O.u6, p0.04). A significant number of children with
uecreasd SD hd a decyaged 6F8 (pO.OQ5), high valuesof PTH (p=D.O1) and a rigs total aese 01 prednisolone
(p=0.04). There was no correlation of BD with immunosu-
pression, primary renal disease and serum calcium and phos-
phate. Bone density is a Sensitive index of bone abnorma-
lities after tx and correlates directly with growth. Graft
failure and the total dose of steroids had a significant
effect on B0. Prevention of bone problems might be possi-
ble with frequent measurements of BD.
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SERUM MAGNESIUM LEVEL AND ARTERIAL CALCIFICATION
IN HEMODIALYSIS PATIENTS
G.Kyrialcopoulosl ,A. Tsoumaa2,K.Kontogiannil and
0. Galanis 2
Renal unit and Biochemical Laboratory Guri.Hospital
of Larisa.
It has bean suggeatad that arterial calcifica—
tions in and—stage renal disaasa are related to a
high serum calcium x phosphorus (CaxP) product,vhi-la no clear — cut ralationship has baan found by
soma recant studios. In this parer we examine the
relationship of serum levels tf Ca,p,CaxP, Mg, P1
Mg, CaxP/Mg, alkaline phosphatasa and iPTh to the
development of paripharal arterial calcification
(AC) in 40 hamodialysis patianta. Tha patients
vera divided into tvo groups. Group A, thosa ahoy—
ng AC and group B, patients in vhom AC did not do—
valop. There yam no significant difference in se-
rum Ca, P, CaxP, alkaline phosphate or iPTH bat—
yuan thy two groups serum Mg was significantly lo—
var in group A than in group B (p<O,001) vhila
thy ratios P/Mg and CaxP/Mg vara significantly
highar.
Although aarum Mg levels poorly reflect the
intracallular Mg content. It is possible that tha
lovmr than aaraga sarun Mg lavals saan in group
A may facilitata the calcification in tha media of
tha arterias since Mg is a potent inhibitor of the
calcification procass. Our obsarvations suggest
that hyparnagnemamia may retard the development
of AC.
TOTAL SEI1OM ACIO PHOSPHATASE (s.ACP): A SIMPLE IIIOEX FOR
THE EVALUATION OF SEC000APY HYPERPARATHYROIOIS(1 OF PATIENTS
ON HAEMOOIALYSIS (HO)
Ch.Stathakis, J.Ooletis, O.Stamatiadis, S.Michael, O.Bri—
stoyiannis, K.Katopodis, A.Katsarov, O.Kiriaki and Or.
Vosnides. Oiyisiom of llaphrology, Laiko General Hospital,
Athens, Oreeca
Although s.ACP sod especially its tartrato resistant
isoemzyme, is the only biochemical index of osteoclastic
activity in pts on HO, its clinical valve has not been wi-
dely studied. In order to evaluate the clinical usefuLness
of s.ACP is the assessment of 2sdary hyperparathyroidise
of pta on HO, this enzyme, as well as, total alkal .phonpha—
tase )ALP), corrected calcium (Ca), phosphate (P) and iPTH
(—C and —N terminals) were determined in the servo of 53
pts (33 M, 20 F), aged 40.5±12.0 yrs, undergoing HO for 5.7
t3.g yrs. A significant (p<O.OU1) positive correlation was
found between s.ACP and servo ALP, iPTH—C and iPTH—N. hen
the pts were separated into those with high (>15 ilL, n=
21), intersediate (10-15 OIL n=14) and low (<10 OIL, n=1U)
s.ACP levels, we observed that: 1) Serum iPTH—N was signi—
ficantly higher is pts with high s.ACP compared to those
with intermediate (pCO.OO1) and low (p<0.O01) s.ACP, as
well an, in pts with intermediate s.ACP compared to those
with low s.ACP (p<O.OO1). 2) Time on HO, serum Ca, ALP
and iPTH—C levels were significantly higher in pts with
high s.ACP compared to those with intermediate (p< 0.001)
and low )p<0.O0l) s.ACP, but did not differ significantly
between pts with intermediate and low s.ACP. Our results
indicate that s.ACP is a aseful index for the assessmenc of
2ndary hyperparathyroidiso of pts on HO, especially its
mild and moderate forms, where s.ACP constitutes a sensiti-
ve, comparable to iPTH—N, indas.
COMPARISON BETWEEN CLASSICAL IIAEMOOIALYSIS AND
HAEMOFILTRATION/HAEMODIAFILTRATION
0. Sakieioq, D. Papadopoulou, K. Ksramitsos, D. Memmos, 0.
Tsakiris, P. Koukoudes, M. Papadimitriou
Renal Unit, Aristotelian Universtity, Hippokration Hospital,
Theesaloniki
We studied 12 patients who were treated with classical haemedialyais
(HO) and subsequently with haemofiltration'(HF) (Group Al, and 5
patients who were treated with HO and heamodiafiltration (HDF)
(Group HI for one year in each mode of treatment.
Mean serum creatinine, K, Na, Ca, P0,, uric acid and haematocrit
were not significantly different in the two groups. There was a
significant difference, however, in serum urea levels between HO and
HF (193±11 vs 220 22 mg% p<O.05) and blood pressure (143 19/
83±7 vs 129±20 / 77±13 mmllg, pc0.05) in Group A. Serum ,-
microglobulin levelewere significantly lower in HF and IJOF
compared to HO. Hospitalisation mao also reduced when patients were
treated with HF and HDF (Group A: 7.1±9.4 vs 2.0± 3,9 days/year,
p<0.01 and Group B: 7.9± 8.5 vs 0.6±0.9, p<O.OOl).
ThE USE OF PARAThYFS3IDECIOMY IN PRIHARY AND SEEX7NDARY
HYPERPARATHY14DIDISM
A H Pierides, An Papanastasiou, P Symeonides, Ch Patsias,
C Ehashe. Depts of Nephrology and Gertral Surgery N.G.1I.
Between Jan. 1 984 and June 1 989, 27 parathyroidectcsmies
have been carried out. 15 patients had primary HP, while
11 patimnts were operated for symptamatic secondary lIP
while on repetitive hensodialysis.
In 12 of the 15 primary patients surgery was carried out
for nephrmlithiasis, while in 3 patients there was
oateitis fibrosa cystica with skeletal pains. Nypercalcamia
was present in all patients fran 11—13.8 mg% while a raised
serum alkaline phopatase was on:Ly present in these patienta
with osteitis fibrosa. Serum P.T.H. was elevated in all
patients and especially in those with concurrent mild
renal insufficiency. At operation 14 of the 15 patients
had a single adenama weighing 1(1—20 yr. 1 patient had
2 adenamas.
In the 11 patients with uranoLc secondary-tertiary NP on
dialysis, hypercalcesnia was muds milder, sto 11 mg% only,but there was o raised alkaline phosphatase. In contrast
to patients with lithiasis soil primary HP these dialysis
patients had signifant post—operative hypecalcaeia
requiring calcium and 1 aOHD3 supplaments. The standard




THE EFFECT OF ERYTMROPOIETIN ON THE ANEMIA, RED
CELL NASS AND BLOOD VOLUME IN CHRONIC HEMODIALY-
SIS PATIENTS
N.Papadogiannskis, C.Matsis, M.Papatriantafillou,
C.Perakis, S.MDutafis, A.Theodoulou, A.Leonti and
A. Vidanopoulos
"Blue Cross" Dialysis Unit
Hematology Lab."Pammakaristos" Heap, and
Isotope Lab. "Alexandra" Nosp., Athens, Oreece.
15 patients on chronic hemodialysis were
placed on erythropoietin (EPO) for the treatment
of anemia at a dose of 50 U/kg, 3 times weekly.
The patients wero on chronic hemodialysis receiv-
ing blood transfusions for the anemia at regular
intervals with subsequent iron overload. Naema-
tological studies were performed before and once
a week the first month after, whereas several
biochemical studies were performed before and
monthly after initiation of treatment. In ten
out of them red cell mass (RCH), plasma (PV) and
blood volume (BV) were measured before, three,
five and twelve weeks after the administration
of EPO.
Anemia was considerably improved with signifi-
cant increase of hemoglobin and hematocrit. Reti-
culocytes and platelets were increased one week
after initiation of treatment but not signifi-
cantly due to large variations.
RCH showed a gradual improvement from 14.9±0.2
before to 17.4±4.6 and 18.9±5.6 ml% after 5 and
12 weeks of treatment. On the contrary, PV was
diminished from 60.2±6.3 before to 57.3±5.8 and
53.0±15.7 ml% after 3 and 12 weeks of treatment.
In conclusion: There is a significant (pcO.Ol)
increase in RCH and significant (p<0.Ol) dimi-
nished pV whereas the total BV remained unchanged.
THE EFFECT OF ERyTNR0POIETIN ON ERVTNROPOIESIS
AND ON RED CELL SURVIVAL IN PATIENTS OF CHRONIC
HEHODIALYSIS
H.Papadogiannskis, C.Natsis, N.Pspatriantafillou,
A.Vidanopoulos, A.Leonti, J.Thanou, C.Perakis and
S .Nuutafis.
"Blue Cress" Dialysis Unit
Hematology Lab. "Pammekaristos" Nosp. and
Isotope Lab. "Alexandra" Heap ., Athens, Greece.
In 7 patients out of 15 who were placed on
Erythropoietin (EPO) for anemia of chronic hemo-
dialysis red cell survival time (RCST)5yas
measured with isotope technique using Cr. The
patients were on chronic hemudialysis from 5-107
months (mean 42 months) and before the admini-
stration of EPD anemia was treated with regular
transfusions with a rate varied in each patient
(mean 18 blood units per patient). EPO was admi-
nistered intravenously 50 U/kg 3 times a week
for three consecutive months.
Anemia was considerably improved after 3
months of treatment and blood transfusions dis-
continued. The mean end SD of RCST before EPO
was found 18.4±2.7 days. After 3 months of trest-
ment it was increased to 23.5±4.3. The mean
increase was statistically significant 5.1±4.3
)pcO.03)
The shortened RCST before treatment corelated
with the duration of chronic hemodialysis and the
number of blood transfusions was found to have
some relation )r=0.56).
The prolonged RCST after treatment was not
found related to the diminished serum bilirubin
and to the increased number of the reticulocytes.
In 3 patients RCST measured 2 weeks after initia-
tion of treatment was found to be almost the same
as after 3 months. This finding leads to the
assumption that the young red cells are more resi-
stant to the hemolytic mechanism seen in patients
on chronic hemodialysis.
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ERyTHR0P0IETIN,OXVGEN TRANSPORT AND FERRDKINETICS
IN ANEMIA OF CHRONIC HEMODIALYSIS PATIENTS
C.Matsis, N.Papadogiannakis, M.Papatriantafillou,
S.Moutafis, J.Papasotiriou, P.Bourdeca,A.Karaklis
Hematology Lab. "PAMMAKARISTOS" Heap.
Hematology Lab. "AGHIA SOFIA" Children's Hoap.
"BLUE CRDSS' Dialysis Unit, Athens, Greece.
In 14 patients undergoing chronic hemodialysis
with severe anemia the effect of erythropoietin
)EPD) on the levels of Hemoglobin (Hb) and the
ferrokinetics was studied. Ferrokinetics included
serum iron (Fe), total iron binding capacity
(TIBC), transferin and ferritin and were measured
before end monthly after initiation of treatment.
In 10 out of them the effect was studied also on
2,3 Diphosphoroglycerate (2,3 DPG) and on oxygen
affinity of Nb IP o' using the oxygen dissocia-
tion curve and th Oxygen Unloading IO2U). These
measurements were performed before the admini-
stration of EPG and after 3 months of treatment.
The dose of EPD was 50 U/kg intravenously 3 times
a week for the first 3 months and was reduced
thereafter according to Nb level.
The results showed a significant fall of Fe
)p<O.Ol) after the first month, whereas ferritin,
transferin and TIBC varied not significantly.
2,3 DPG before (ass 5.6 and after 5.4 tsmoles/ml.
P mean values before were 30.9±3.5 and
a€er 29.4±0.6 mm Hg.
The results also showed reduced 0 U before
trestment increased significantly sfer 3 months
of treatment.
RED CELL AND IRON KINETIC STUDIES ON HEMODIALYSIS
PATIENTS BEFORE AND UNDER RECOMBINANT ERYTHROPOIETIN
THERAPY
T.Tsobanelis. P.Kurz R. Weitz—Miesne,*U. Ewald, *P.Roth, *E.Werner.
P.GrUtzmacher at I .Vlschojsnnis
II. Med. KIlnik Akad. Krankenhaus St. Markus Univ. Frankfurt, FRG
*Geneilschaft für Strahien— and Umweltforschung Frankfurt. FRG
a*Nephrology Center IJniversity Patras , Greece
With recombinant erythropoietin )rEPD) sn effective therapeutic tool
for the treatment of renal anemia has been introduced. Kinetic stu-
dies using iron isotopes help as to investigate the pathon<echanisms
of the ineffective erythropoiesis especially under rEPO therapy.
Nine)9) hemodialysis patients received rEPO therapy Idose 4D IE/kg
KG. three times per week). rCPO was given intravenously at the end
of each hemodialysis treatment.All patients had a severe renal ane-
mia with a mean hematocritlHCT) of 22%.lron kinetics studies were
performed before and 4 weeks after initiation of rEPO therapy.After
application of the iron and chromiam)59Fe-SlCr)isotope the following
parameters were determined using whole body counter: hemoglobin
productior ratelHb-SR g/dl, bone marrow iron turnover )MIT mg/dl.
red cell iron turnoveriRCiT mg/d) and red cell survival time.
rEPO HCTI%) ferritinlçvg/llHb-SR)g/dl MIT)mg/d) RCITIm9/dl
before 22.0±1.1 863±330 4.2±0.5 16.4±2.1 t4.5±t.8
under 29.2±1.6 478±189 5.9±0.5 23.tst.7 20.5±1.8
p <0.01 n.s. <0.05 <0.05 <0.05After 4weeks of rEPO therapy a significant rise of HCT and a mar-
ked fall of ferritin were observed. The iron kinetic results showed a
significant increase of hemoglobin production rafe, bone marrow iron
turnover and red cell iron turnover. Red cell survival time as well as
blood losses were unchanged under therapy.One patient did not show
a rise of HCT under rEPO. This patient already had high values for
MIT and RCIT prior to therapy and no additional stimulation was ob-
served after 4 weeks rEPO therapy.
lv conclusion, our results show that rEPO abolishes funct:onal bone
marrow insufficiency iv dialysis patients. Erythropoiesis :s normal:zed
and bone marrow turnover rises.Thus this method may help to mea-
sure bone marrow response to rEPO and to differentiate responder
and non-responder of patievts with high iron store.
TREATMENT OF THE ANEMIA OF CHRONIC RENAL FAILURE WITH LOW
DOSES OF RECOMBINANT HUMAN ERYTHROPOIETIN (r—HuEFO)
G.Stavianoudakis, G.Vosnides, N.Fapadodimas, M.Siakotos,
C.Stathakis, G.Metauatos, E.Sarris, N.Tsianas,
M.Tziamalis, O.boumenos, A.Eiillis
Division of Nephroloqy, !Evangelismos!, Laiko aod Tzaonio
Hospitals, Atheos, Greece
In order to evaluate the effectiveness and safety of low
doses of r—HuEFO, we administered it to 12 patients (pts)
(B M,4 F),aged 17—79 years, who were on chronic
hemodialysis (10 pts( or CAFO (2 pts) for 6—116 months and
had severe ,transfusion—dependent anemia. During the first
3 months of treatment, r—HuEFO was given IV 50 to 75
u/kg, 3 times/week and thereafter the dose was adjusted to
keep the Ht level around 32X. A consistent increase of Ht
was observed after 3 months in all pts from a mean value
of 19,87. to 32,47. (p<0,00l);thereafter ,the Ht remained
stable till the end of the follow—up period (4—12 ,mean 9
months) with a mean weekly dose of r—HuEFO 123 (range 50—
2251 u/kg .A remarkable improvement in the quality of life
of pts was also seen. There were no significant changes of
serum creatinine,potassium,and phosphate. Serum ferritin
fell progressively throughout the study from 1428±1425
og/mI to 637±640 ng/ml (O.l>p)O.05) and iron supplementa-
tion was required in 7 pts. Mild side—effects, which
subsided without discontinuation of treatment, were seen
in 5 pts ("flu'—like symptoms in 2,mild hypertension in 3).
In conclusiun, low doses of r—HuEFO were effective in
correcting the aoemia and improving the quality of life of
pts on dialysis without significant side—effects.
LEFT ATRIAL VOLUMES AND PRESSURES CHANGES DURING
HEMODIALYSIS
C.Stratos, C.Stefanadis, J.Kakavas,
P.Kotileas, G.Bougatsos, M.Apostolidou E.Kardouli, H.Bou—
doulas, S.Voudiclari, P.Toutouzas.
Department of Cardiology of Athens University and Depart-
ment of Nephrology of Hippokration Hospital, Athens. Greece
Left ventricular function in patients on mainten-
ance hemodialysis has been studied. No information, howe-
ver, is available concerning the left atrial (LA) function
in these patients. The purpose of this study was to evalua-
te the changes of the LA volumes and pressures occuring
during hemodialysis. Twenty patients with chronic renal fai-
lure were studied just before and after hemodialysis. The
LA volumes just at the onset of mitral valve opening, the
onset of LA systole, and the completion of mitral valve clo-
sure were measured from the 2—D echogram using the biplane
rea_length method; the LA pressures were estimated indire-
ctly from the pulmonary capillary wedge pressure (PCWP)
using a flow rated, fluid filled catheter. Also, the card-
iac output was measured using a thermodilution method.
Results: 1) The LA volumes decreased (at the onset of
mitral valve opening b3y 6±3 cm3, p=D.D5, at the onset of LA
systole by 8.5±2.5 cm , p<D.Ol, and at the completion of
mitral valve closure by 5±2.3 cm3, p<O.D5), 2) The mean
PCWP decreased by 5±1 me Hg, p<O.Dl, and 3) The cardiac
output did not change significantly.
In conclusion, left atrial volumes and pressures change
significantly with hemodialysis. These changes may be con-
tribute in the omeostasis of circulation via the left atri-
al function or/and via the baroreceptors of the left atrial
wall.
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TME EFFICIENCY OF LOW DOSE ERYTHROPOIETIN IN CHILDREN
ON HEMODIALYSIS
A.Mitsioni, D.Siapera, K.Stephanidis, Z.Karakatsani,
A.Zoidou, K.Michelis.
Division of Nephrology "P & A.Kyriakou" Children's
Hospital, Athens - Greece.
The efficiency of recombinant human erythropoietin(rHuEpo)
in children with end stage renal disease is well establi-
shed. However little is known about the dose qf rHuEpothat
can correct anemia in those patients. Low doses of rHuEpo
(75 U/KG/wk) were administered in 7 children (8 to l8years
of age) on hemodialysis for 36 weeks. The hemodialysis pe-
riod before rMuEpo treatment was g to 72 months and the
interval of blood transfusions was 21-52 days. The dose of
rHuEpo was 75 U/KG/wk IV and was increased in 3/7 children
after 14 weeks of treatment, because of poor response.
During the rHuEpo period, all patients were transfusion
free. However a difference of their response to rHuEpo was
noticed. 3/7 children responded with the initial dose (hHb
2.4-5.5 g/dl), 1/7 responded with 150 U of rHutpo/kg/wk
(AHb 2.2 g/dl) and 1/7 did not increase his Hb with
DDDU/KG/wk, finally 2/7 had an initial response (ftHb2.2g/dl)
and a drop of Hb was noticed at the 28th wk of treatment
without Fe deficiency. There were no significant differen-
ces in serum Fe and feritin before and after rHuEpo treat—
ment.There were no significant side effects. Hypertension
occured in one patient and 2/7 hypertensive children remai-
ned in the same doses of antihypertensive medicines. Hepa-
ne on hemodialysis was increased in 6/7 children.
In conclusion a low dose of rHuEpo is safe and efficient
in most children on hemodialysis. However a low and delayed
rise of hemoglobin was noticed with this treatment.
rREFUENCY OF PAINLESS JIYOCARDIAL ISCHAEMIA IN CHRONIC HE—
MDDEALYCED PATIENTS
J.Paraskevaidis, N.Kallivretakis, S.Limpeni, G.Theodorakis,
A.Slotta, J.Tjanakis, M.Sonikiao.
Department of llephrolooy Hippokration General Hospital and
Department of Cardiolopy General Hospital Athens.
To evaluate the frequency of painless myocardial i-schaemia
4S patients underooinp reqular hemodialysis underwent
Holter ECG nonitorinq for a continuous 4D-hosrs ooriod co-
verinp dialysis and the intermediate period of everyday a-
ctivity at hone. All patients underwent left and riqht
heart catheterisation, left ventricsloqraphy and coronary
artenionraphy.
Seven patients (15.51) aped 41±3 years had episodes of S-T
seqnont elevation of 1.18±0.7 cv and S.19±D.5 mis duration
without ansina. Coronary artery disease was found is 3 pa-
tients only (6.4%). No sionificant correlation was found
between the depree of anaemia, 8P, LV hypertrophy, LV per-
foroance, body weioht loss and biochemical profile esept K'
before and immediately after heeodialysin. The K' level
differences (0.7±1.2 mEo/l) were highly correlated with the
eoisodes of silent ischaenia (p<D.DODDD1 ).
In conclusion potassium (K') seven to play an important ro-
le possibly in combination with other factors in the qene-
sis of coronary constriction.
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SUCCESFUL RENAL TRANSPLANTATION FROM LIVING
DONORS WITH A POSITIVE STANDARD DTT NEGATIVE
C ROS S MA T CH
M. Varla-Leftherioti, P. Douramani,M.Papanikolaou
G.Sotirhos ,M S8yropoulou,Al .Kostakis,
C.Stavropoulos-Giokas
-Immunol.Tissue Typing Lab. Gen.HospTrt.of Athens
- Transplant Unit. Gen. Laiko. Hosp. of Athens
It has been recognized, during the last
years,that kidney transplantation can be succes-
fully performed in the presence of a positive
crossmatch under certain conditions.This year two
patients have been succesfully transplanted in
our center from their living donors accross a
positive standard crossmatch. These were two SLE
patients 34 and 46 years old who were waiting for
a transplant for 4 and 6 yrs respectively. All
sera tested dirin these years had a strong re-
activity (40-95%) but not any 'specificity"
against the panel and crssmatches with their liv-
ing donors were positive when the standard techni
que was used. Further investigation showed posi-
tive auto-crossmatches no reactivity with lympho-
cytes from CLL patients and the antibodies disap-
peared when sera were treated with NaCl in 70°C.
Finaly, after treatment of the sera with DTT
(diluting sera 1:2 with a 0.01 M solution of di-
thiothreitol) panel reactivity and crossmatches
became negative.After the characterization of the
abs as auto 1gM, the two patients recieved kidneys
from then living dostors.Both recipients have well
functioning grafts 3 months afther transplanta-
tion and none of them had rejection episodes.
In conclution,a detailed investigation for the
detection of the antibody specificity and the
immunoglobulin class as well as final crossmatch
using DTT should be performed and, if it is nega-
tive, transplant can be encouraged even in living
related transplantation.
P-\TIENTS REGISTRATED FOR KIDNEY TRANSRLANTS
IN THE CREEK bAITING LiST.
N.Kaloudi,M. Sarr is ,A. Macrynicola ,C. Stavropoulos-
Giokas ,M.Varla-Leftherioti
Hellenic Transplant Service (YSE)
Data are presented on patients waiting for
renal transplantation in Greece.
At the end of 1989 813 patients were registrated
in the list,521 men and 292 womqn while in 1988
the candidate recipients were 643.The blood group
distribution was:A:39,4%,O:43,7%,B:ll,9% and AB:
4,4%.As for the age 1,2% of the patients were
under 15 v.old,11),5°, between 15 and 30,72% bet-
ween 30 and 55 and 23,46 were over 55 y.old.
The mean time since first dialysis up to the re-
gistration time was 48 months and the mean wai-
ting time 25,64 months.87,6% are waiting for a
first transplant while 12,3% for second or third
and 26,44% of the candidates are also registra-
ted in waiting list of forcing cantries
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AMELIORATION OF CYCLOSPORIN-A NEPHROTOXICITY
BY NIFEDIPINE AND PIRACETAM ALONE OR IN
COMBINATION.
D.Grekas, P.Allvanis, l-l.Kalekou, A.Papaylanni, M.Karanouzis,
V.Derveniotis, I. Kalevrosoglou, M .Pyrpasopoulos, A.Tourkantonis.
Renal Unit, University Hospital AHEPA, Thessalonlkl Greece.
The aim of this study is to assess the effect of nifedipine
and piracetam alone or In combination in the protection of
renal function and morphology after cyclosporin-A (CyA)
administration. Thirty healthy mongrel dogs with a mean
body weight of 15kg were sacrificed. Six animals (group C)
were given CyA 20mg/Kg body weight per os, while the rest
groups (of 8 animals each) were given concomitantly 20mg
nifediplne (group CN) or 8gr piracetam (group CP) or both
drugs in combination (group CNP). After five days of drugs
administration the animals were anesthetized, both kidneys
were exposed and functional tests were performed. Then the
kidneys were removed for histological study. The mean plasma
CyA levels in the four groups were 1765+685, 1300+324,
1116+491 and 1600+290 ng/ml respectively. Urine volume,
creatinine, urea and osmolar clearances were significantly
higher In the groups CN, CP and CNP compared to the control
group C (p°0.01). Urine sodium concentration and FENa(%)
were found significantly higher (p0.01) in nifedipine groups
than in the rest twp groups of animals. Plasma
thromboxar,e-B2 levels were significantly reduced by each
drug alone or by combination (pv0.01). Histologically, cortical
tubu!ar lesions (tubular vacuoiozation, isolated necrotic cells)
were found in all groups of animals in a similar way. It is
suggested that the effect of both drugs given separately or
in combination is beneficial in terms or tne reouctuon or
tne CyA nepnrotoxicity.
F€aLTS IN 250 FENAL 1l4AN91JNAT ICNS
A.Kosbe<i s,St .Kyr'i*idis,z.Gsrbis,K.Oi I es,G.Sst rd-tcs,G.Za,os ,B.Athaia-
sailias,0 .Statl-<i s,A5graf ci s,;.ijrati s,VYatzi costat nra ,A.Stairm-
pwlos,A.Bilis,Gr.Vog-,idis,JfIa-tstas.
Tralastat ira Ce-nter,Ge-neral Laiiccn l-dspi tal ,(di ,Athets,Greece.
Drirg the penicd Nrrh'83-Ec. 89,250 reel tretsplantat ms mere perf or-
nimi in oironit,of vhid-,in 159 pts(ll2vi, 41)grufts mere froslivirm re—
lataido-mrs(grm.p l)a-d in 91 pts(54 ,35F)ceeericgraftsvereuset
(grup Il(.Recipimts acre further divid in 3 atmro.4zsa000rdirc to the




nuletive ajrvisal rate(C)in Ia ems 91% for the 1st yr,S1% for the 3rd
ad 81% for the 3d,in lb 71% for the lat,3rd ed 3rd yr respect ively,ad
in Ic 41% for the 1st yr, 21% for the 3rd ad 21%f or the 3rd yr.A statisti—
rally sig-ifira-n differe-,ce eas dssere1 in graft C89 betemet la-lc(Lrm-
na-Is test,x2=13,71,P(O,oJl)a-ri lb-Ic(X rd,03,P40,1).The respective CSR
of pts in a ems 9%,91%a-d 8,in lb 8L8%,8/4%a-d &%axi in In 81% for the
let ard 71% for the lid ad 3rd yr.StatitireIly sigtifiratt diffrtce of
ptaCE1 eec dtservel betmeor Ia ad lb(X °3,85,P(O,05)axl la-lc(X °8,38,
P(O,O1).Grup II: CSR for grafts in ha ems 81%,71%,1%foi- the first 3yrs
in I lb 61%,51% ad 51% respectively ad in I Ic 61%,41% ad 4(.Statjst sI -
ly sigtificm-it differetce in graft CSR ems ford betacen lie—I Ic(X =5,82,
P(O,05).The Pt CSR ems in lie 9l%for the 1st 3rd ad 3rd yr',in I lb 6t%,
ad 81%ae. in hr 81%,%,8(% respectively.he sig-iifinant differetce ems
ford in the last s±mro4ns.
In crnclusicn me bel iree ti-mt the triple dn n-spine-n is better then the
others beca-me it offers better graft a-dpt CSlR ad became enwi ler doses
of dogs are usaj mi th loser cost ad ajoirhnce of dog a4,erse effects.
